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ABSTRACT 
The General Adaptation Syndrome (G.A.S.) was characterized 
for chronic forced restraint stress in normal and reserpinized 
(1 mg/kg, I.P.) male albino rats. This was accomplished by 
analyzing the interrelationships among brain neurohumoral levei1 
(serotonin (5-HT) and norepinephrine (NE) ), serum corticoster-
one (KS) levels, and various organ weights such as thymus, 
testes, pituitaries, and adrenals. 
Reserpine was observed to prevent normal rats from adapt-
ing to this stress (mortality rate was 50~) possibly via inani-
tion. It was suggested that the overall non-adaptive effects 
produced could ultimately be due to the ability of reserpine 
to induce a chemical sympathectomy. Thus, by depleting the 
A.N.S. of accessible NE, an animal would be unable to respond 
to a severe change in environment. 
Control animals demonstrated both behavioral and neuro-
chemical adaptation in response to this stress. Initial ex-
citation associated with restraint was related to increased 
brain 5-HT levels and decreased brain NE levels. As the ex-
periment progressed, stress animals became less excitable and 
easier to handle which was also associated with the return of 
both bra in am in es to norm al levels. 
In contrast, reserpinized animals subjected to chronic 
restraint stress became progressively rrore excitable and diff1-
cul t to handle as the experiment proceeded. This behavior can 
iv 
best be described by C.N.S, depression associated with extreme 
hypersens1t1v1ty to handling. This progressive change in be• 
havior was correlated with the progressive depletion of brain 
NE levels, since brain 5·HT remained at relatively normal levels. 
The progressive increase in excitation thus appeared to be de-
pendent on NE depletion or release. 
Reserpine (1 mg/kg, I.P.) induced a progressive depletion 
of brain NE while it did not do so with 5-HT. This was inter• 
prated as indicating that 5~HT synthesis was equivalent to its 
release, In contrast 0.5 mg/kg, I.P., of reserpine was found 
to produce a progressive depletion of 5·HT as well as NE. On 
the other hand, higher doses of reserpine inhibited the sero-
tonin depletion effects produced by the l mg/kg. In fact, some 
animals demonstrated levels above normal following the chron1o 
administration of reserpine (2 mg/kg, I.P.). Therefore, a 
poss1ble serotonin•feedbaok mechanism involving the free and 
bound oonoentrations of this amine may be 1nd1oated. 
Increased brain 5wHT levels twenty~four hours after the 
th1rtyMseoond dose of reserpine was also suggestive of an ina 
creased synthesis rate. Behavioral exo1tabil1ty was also 
found to oharaoter1ze these increased serotonin levels in all 
experiments oonduoted, Norepinephrine, on the other hand, 
did not demonstrate any observable changes 1n the rate of syn ... 
thesis u·nder the influence of ?'eserpine. 
v 
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I, INTRODUCTION 
The ability of an animal to adapt to both internal 
and external changes in environment has been known to be 
essential to life since Claude Bernard's discussions on the 
"Internal Milieu". Mod ern research in this field has 
amassed evidence which clearly indicates that adaptation to 
changes of env i ronment or to a stre ssor i nvo l ve s an int er -
play be tween the central and autonomic nervots systems and 
the endocrines, especially the pituitary-adrenal axis. The 
fact that adaptation involves nervous activity has led to 
studies of the effects of various drugs acting on the cen-
tral nervous system on these interrelationships. 
Tranquilizers such as reserpine have been especially 
studied because their sedative effects indicate an inhibi-
tion of the pituitary-adrenal axis. However, much to the 
surprise of previous investigators, reserpine produced 
either depression or stimulation of the pituitary-adrenal 
axis in response to acute stressors. These investigators 
studied reserpine in animals subjected to various stressors, 
but due to great variation in methodology and experimental 
design, divergent views of the effects of reserpine resulted. 
To reconcile this state of appar ent confusion r ecent 
investigators have pres e nt e d strong evidence indicating that 
reserpine stimulates pituitary- adrenocortical function and 
does not inhibit stress acutely. Although this work is well 
1 
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documented, little consideration of the chronic effects of 
reserpine in stressed animals has been observed. A few 
isolated experiments on the effects of the chronic adminis-
tration of reserpine in normal animals have not resulted in 
conclusive statements as to specific pituitary-adrenal inter-
actions. Along with this, little thought has been g iven to 
the study of the chronic effects of reserpine on its proposed 
central nervous system mediators of tranquilization, norepine-
phrine (NE) and serotonin (5-HT). 
In view of these inadequacies, this investigation was 
designed to study of chronic effects of reserpine on the 
pituitary-adrenal axis and its proposed C.N.S. mediators of 
tranquilization. It has been the prime purpose of this in-
vestigation to study the interrelationships of the pituitary-
adrenal axis and the brain neurohumoral agents NE and 5-HT 
with the behavioral sequences observed during chronic reser-
pine treatment in unstressed and chronically stressed rats. 
The significance of this research will reside in its ability 
to clarify the mode of action of reserpine in view of attempt-
ing to correlate these data with human pharmacology. 
II. REVIEW OF THE LITERATURE 
Adaptation 
The problem of animal adaptation has interested biol-
ogists for some time and has now become of interest to the 
pharmacologist since it has been realized that any drug 
could be considered a stressor to which an animal should 
adapt. Claude Bernard was first to recognize the neces-
sity to maintain an internal constancy under any environ-
mental change. Other investigators, including Fredericq, 
Pfluger, and Richet (Cannon, 1932) were also quick to real-
ize that in order to carry out such equilibrations under 
environmental changes, an animal must possess some regula-
tory mechanism which could quickly and efficiently meet 
these provocative insults. 
W. B. Cannon in attempting to solve this problem 
suggested that the autonomic nervous system (ANS) is the 
initiator of adaptive mechanisms. He also recognized the 
remarkable ability of an animal to maintain a varying in-
ternal environment within limitations so as to hold a rel-
ative constancy. This he termed Homeostasis. Cannon 
wrote: 
"Here then is a striking phenomenon. 
Organisms composed of material which 
is characterized by the utmost incon-
stancy and unsteadiness, have somehow 
learned the methods of maintaining 
constancy and keeping steady in the 
presence of cocditions which reason-
ably might be expected to prove pro-
foundly disturbing." 
3 
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Cannon proposed that under environmental changes, A.N.S. 
stimulation, and espec:t.ally plasma adrenalin, could initi-
ate cellular preparadness, and therefore, permit adaptation. 
His main methodological approach was total or partial sym-
pathectomy. Homeostatic responses were then observed under 
normal and stress conditions. To better appreciate his con-
clusions a passage from his monograph on Homeostasis has 
been cited: 
"If sympathectomized animals were set free 
in the outer world and had to meet its 
demands in struggle for food, safety and 
warmth, they could be found more or less 
defective according to the variable effi-
ciency of their accessory stabilizing 
mechanisms. Even in the most favorable 
conditions displayed by the sympathectom-
ized dog, however, absense of sympathetic 
control of corrective devices is accompa-
nied by an inability to preserve constancy 
of the internal environment though the 
stress is only moderate." 
Not being satisfied with Cannon's theories, Han Selye 
(1950) began a long series of experiments demonstrating 
that any animal presented with a noxious stressor responds 
in a very characteristic pattern elicited by adrenocortical 
hyperfunction via anterior pituitary stimulation. Because 
of the impact of his research on modern thinking concerning 
homeostatic mechanisms, his major postulates are now out-
lined: 
I. When an animal is presented with some drastic 
change of either its internal or external en-
vironment, the pituitary-adrenal axis is stim-
',• . 
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ulated, eliciting an increase in plasma corti-
costeroids. These steroids are believed to be 
the substances enabling an animal to adapt to 
these changes. 
II. With prolonged stress a complete adaptive syn-
drome can be characterized, known as the General 
Adaptation Syndrome (G.A.S.). 
III. The adaptive trigger, the anteriory pituitary, is 
essentially controlled by the hypothalamus. 
IV. There is no essential qualitative difference in 
the responses to different chronic stresses. The 
differences are basically quantitative. 
Cannon's and Selye's theories do not conflict but tend 
to expose the true overall picture. Cannon worked on the 
adrenal medulla whereas Selye studied the adrenal cortex. 
There is now little dcubt of the central position of the 
pituitary-adrenal axis in adaptation, but A.N.S. activity 
is assuredly not without importance. George Sayers (1950) 
has compared these relationships in much clearer a fashion. 
He states that the adrenocortical hormones play a general 
supportive role rather than an initiating role in bodily 
processes; whereas the adrenal medulla initiates cellular 
and metabolic changes in response to an emergency. The 
adrenal cortex plays a passive role and makes it possible 
for various regulatory systems to expend the additional 
effort necessary for homeostatic adjustment. 
6 
The Pituitary-Adrenal ~xis 
The relationship between adrenocortical activity and 
the pituitary was first demonstrated by Smith (1927). By 
extirpating the pituitary of the rat, he was able to demon-
strate a rapid adrenocortical atrophy due to hypophysectomy. 
Since this clas s ic investigation, numerous steroid hormones 
have be en i solated and identified as either s ecretory or 
bio synthe tic precurse r subs t ances of t he adrenal cort ex. 
The r e l ease of the se hormones into the general circulation 
has been found to be dependent upon the elaboration of a 
hormone released by t he pituitary, the adrenocorticotrophic 
hormone (ACTH) (Vogt, 1960). It has further been observed 
that numerous types of stirrmli (stressors) including chem-
ical, physiolo g ical and psychological, induce ACTH release, 
thus producing a secondary release of the adrenocortical 
hormones . 
Recently it has also been demonstrated that in addi-
tion to a negatfve feedback effect of plasma corticosteroids 
on the pituitary, ACTH is also regulated by higher centers 
of the C.N.S., particularly the hypothalamus (Harris, 1955). 
However, another mediator substance has been postulated as 
being responsible for ACTH release during stress situations. 
This second mediator has been postulated since there are 
no direct nervous connections between the hypothalarrms and 
anterior pituitary. Saffaran (1962) has accurrmlated evi-
dence supporting this view through the extraction and partial 
7 
purification of a hypothalamic factor which will induce 
ACTH release from the pituitary in vitro. 
The General Adaptive Syndrome 
As mentioned previously, Hans Selye has characterized 
a syndrome of chronic animal adaptation (1950). Selye has 
conclusively demonstrated the dependence of this syndrome 
on the pituitary-adrenocortical function through the 
classical methods of endocrinology of extirpation and re-
placement experiments. An animal which is presented with 
a chronic stressor, will undergo three distinct stages of 
change. An initial stage, or alarm reaction, a secondary 
stage of adaptation and finally a stage of exhaustion. 
During the first stage, which may last from one to 
three days, physiological changes, such as lowered blood 
pressure, decreased body temperature, C.N.S. depression, 
and antidiuresis, are observed. During the second stage 
the stressor will be compensated for, and these physiolo-
gical responses will return to normal or even increase. 
This second stage will continue until the animal can no 
longer adapt to or compensate for the stressor and the ani-
mal will pass into the exhaustive stage and eventual death. 
There are several organ weight changes which characterize 
each peculiar stage of this syndrome. In general, an increase 
in adrenal weight, a decrease of both the thymus and gonadal 
weights are indicated during the alarm reaction. During the 
latter stages of the syndrome similar changes will persist or 
return to normal. In terms of hormonal controls, these are 
8 
associated with increased hormonal activity whereas a de-
creased organ weight is associated with decreased hormonal 
activity. 
Throughout th is syndrome several biochemical patterns 
also change ind i ca ting spe ci fi c homeostatic adj us tmen ts. 
Changes in the biochemistry of the adrenal gland are indi-
cative of ino1•ea.sed adrenal activity. Increases of adr•eno .. 
corticosteroid output and decreases in adrenal cholesterol 
and ascorbic acid have been found to be good indexes of ad ... 
renocortical hyperactivity. Within the past four years me-
thods for the direct analysis of plasma and adrenal cortico-
steroids have also been developed (Guillemin et al (1958). 
This development has very greatly enhanced recent endoorin-
o logical and pbartna co logical 1 nvestiga t ions concerning the 
pituitary-adrenal axis. 
Thus, as one can see, adaptation involves many homeosta-
tic mechanisms. The sequence of events from the initiation 
of the adaptive trigger to the final release of a.drenocort1 ... 
cal hormones into the general circulation, involves several 
chain reactions which are basically controlled through feed-
back mechanisms. Therefore, theoretically a drug could either 
stimulate or depress any one of these mechanisms and thus alter 
the end result. It should also be a.ppa.rent that although adre ... 
11ocort1cal aet1vity may \Je either stimulated 01• inhibited by a 
drug, th is does not 1'119 an that th1 s drug p reduces its effects 
via the C.N,S. alone. 
· ... 
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PERIPHERAL NERVOUS 
SYSTEM 
lA 
C.N.S. 
HYPOTHALAMUS 
(LIMBIC SYSTEM) --
1 
CRF 
ANTERIORf PITUITARY I ,,_ \ 
ACTH 
.I 
I 
ADRENAL co R TEX I 
coRTrc6smRo r~s l 
ks .J. 
? 
• 
ADRENAL 
MEDUL!.A 
t 
E/NE 
Fig. 1 . A theoretical representation of the hypothalamtco-
adenohypophyseal-adrenocortical axis and drug action~ 
~Possible Sites of Drug Action 
(Inhibition or-stimulation) 
1. Drugs can inh ib 1 t any segment of the nervous 
segment (A-) 
2 . Drugs can act on any of the hormonal secretions 
CRF, ACTH, anu KS 
They could affect any one of the following 
aspects of hormonal secretions: 
1. Synthesis 
2. Release 
3. Site of action 
Fig. l 1s an attempt at presenting the possibilities of 
where a drug could attack the pituitary adrenal axis. As one 
can see there are more than a dozen ways of affecting this 
system and still obtair1ing the same end result, either st1mu ... 
lat1on or 1nh1bit1on of corticosteroid release. The most im-
portant point to be made here is the fact that so me 1nvest1-
ga tors after de term 1ning the effects of a. dn1g on the adrenal 
10 
corticosteroid will then draw conclusions without examining 
drug effects on the intricate sequence of events outlined 
above. 
The ~of Action of Reserpine 
Reserpine is a crystalline alkaloid obtained from the 
plant Rauwolfia serpentina (Schlittler et al, 1954). This 
drug has been known since the time of Arab and Greek physi-
cians and was used in Europe for many years in the treatment 
of various anxiety states. Due to technical difficulties, 
reserpine was not isolated nor characterized until 1952 (Mueller 
et al), when its sedative and hypotensive effects were also 
first exposed. Although aggressive animals such as monkeys 
could easily be handled after the administration of reserpine, 
the animals did not go t o sleep and they could respond to all 
external stimuli. This new type of sedative activity was de-
fined as "tranquilization". 
The mode of action of reserpine is one of the most inter-
esting and challenging problems confronting current pharma-
cology. Because of its d if.t'u se pharmacological effects, the 
mode of action of reserpine has escaped most investigators. 
This problem, however, is not peculiar to reserpine, for in 
dealing with drugs which affect the psyche, one has the over-
whelming problem of attempting to eva.l ua te changes in animal 
behavior. 
1. Electrophysiological Mechanisms 
The first pharmacological investigations of reserpine 
indicated that reserpine inhibited the hypothalamus, initiating 
11 
sympatholytic or parasympathomimetic effects (Plummer, 1954). 
Since these early investigations as to the effects of reser-
pine on brain electrophysiology, its effects have been obser-
ved to be increasingly more complex and diffuse. Depending upon 
the dose used, methods of electrical recording and stimulation, 
and on the species of animal used, one observes either facilita~ 
tion or inhibition of many brain areas. Domino (1962) summarizes 
the effe~ts of reserpine on various electrical systems of the 
brain by concluding that reserpine either stimulates or depres ses 
most areas of the brain, except for the Limbic System which it 
facilitates. 
In studying the behavioral pattern of reserpine, Weiskrantz 
(1957) observed that reserpine appears to inhibit sensory input 
to the brain. Jacobsen (1959) further studied reserpine under 
psychic stress and found that it produced very nonspecific 
effects. He also stated that the general stupor produced by 
reserpine prevented the observation of possible specific effects. 
The major problem associated with the study of reserpine 
can be summarized best by Bein (1957). He states: 
"Reserpine, which exhibits a complex pattern of 
activity, differs from other known substances 
having central inhibiting activity, and its 
mode of action is of a fundamentally new type." 
2. Neurochemical Me chanisms 
Current inte res t in the effects of reserpine on brain neuro~ 
humeral agents was initiated by the observation that reserpine 
has the ability to reduce normal brain levels of Serotonin (5~HT), 
(Pletscher et al, 1956). Since reserpine could not be detected 
in the brain during maximal sedation, Brodie and Shore 1957 
12 
proceeded with the theory that it exerted its effects by re-
leasing the normally bound 5-HT which would then be free to 
inhibit central synapses, thus producing tranquilization (1957). 
Holzbauer and Vogt (1956) also found that reserpine de-
pleted norepinephrine (NE) from its normal brain stores and 
concluded that reserpine acted as a sympatholytic agent. 
Carlsson et al (1 957 ) demonstrated that 3:4 dihydroxyphenyla-
lanine (DOfA), one of the precursors of NE, restored the 
normal activity of reserpinized animals, presumably via the 
restoration 01 depleted brain NE. When a reserpinized animal 
was administered the precursor of 5-HT, 5-hydroxytryptophan, 
no change of activity occurred. Carlsson (1958) has further 
demonstrated that reserpine depletes 3-hydroxytyramine (dopa-
mine), a precursor of NE which is now believed to also possess 
a physiological role of its own. Therefore, Carlsson theorized 
that reserpine produces its effects by depriving central synapses 
of accessible NE and dopamine. (This is what Holzhauer and Vogt 
essentially proposed.) 
Paasonen (1961) aided Carlsson's theory by observing that 
raunescine, a rauwolfia alkaloid, also produced sedation similar 
to reserpine, which selectively lowered NE to a greater degree 
than 5-HT. He, however, utilized b1oassay procedures for brain 
NE and 5-HT determinations as opposed to Brodie's fluorometric 
procedures. Pletscher et al (1959) were also able to demon-
strate differential effects of various benzoqu1nol1z1ne deri-
vatives on these brain amines. From these studies they showed 
that the compound with the greater sedative effects, also pro-
duced a greater depletion of NE than of 5-HT. 
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Although evidence has been presented contradicting Brodie's 
original postulates, he has been able to withstand these attacks 
with very convincing evidence that reserpine does produce its 
effects through 5-HT depletion. The present evidence supporting 
this theory is outlined as follows : (Brodie et al, 1961, Burns 
and Shore, 1961) 
1. Reserpine causes equivalent depletion of both NE 
and 5-HT from their normal bound states in the brain. 
2. Brain levels of reserp ine cannot be detected at the 
onset of its sedative effects and depletion of both 
amines. 
3. 5-hydroxytryptophan produces sedative effects similar 
to that of reserpine. 
4. Reserpine appears to affect the binding of 5-HT 
rather than its synthesis. 
5. Alpha-Methyl-m-Tyrosine depletes the brain of its 
NE stores without demonstrating sedative effects. 
6. Cold stress (4° ) four hours prior to the administra-
tion of reserpine prevented its sedative effects. 
Similarily it also inhibited the depletion of 5-HT 
induced by reserpine, but not that of NE. 
In a more recent paper, Revizin et al (1961) studying the 
effects of alpha-Methyl-m-Tyrosine, tetrabenazine and reserpine, 
demonstrated excellent correlation between CNS depression, 
evoked Limbic potentials (reserpine usually causes facilita-
tion, Domino, 1962), and lowered 5-HT levels. They could show 
no relationship between NE depletion and evoked potentials. 
This last investigation is extremely interesting and important 
in view of the fact that it is one of the few attempts at 
co r relating CNS behavior with electrical and chemical events. 
It shou ld also be pointed out that most of this work in-
volves whole brains with little regard as to what occurs at 
the intracellular level. In an effort to overcome this defi-
ciency Giarm n and Schanberg (1950) and Weil-Malherbe et al 
(1961) studied .. en t :o if'uged brain fractions from reserpinized 
animals . Giarman working with 5-HT and Weil-Malherbe working 
with NE found that r ese r p i ne increase s the FREE/BOUND ratio 
of the concent r ations of both amines. Thi s ratio refers to 
the concentrations of amin~s of the cytoplasmic fraction to 
the concentrations of the amines in the particulate fraction. 
The significance of these previous investigations points to 
the ability of reserpine to increase the concentrations of NE 
and 5-HT in the "Free" form. It is assume d that the "Free" 
form of either amine is that quantity accessable to central 
s yna pt 1 c s it e s • 
Effects of Reserpine ~ the Pituitary-Adrenal ~ 
Past research on the mechanism of the action of reserpine 
has e mphasized the brain neurohumoral agents, 5- HT and NE. 
However, within the past two years, renewed interest in the 
effects of r e serpine on the adrenal cortex has been noted. 
The endocrine aspects of re fe rpine (0*5 - 1.0 mg/kg) were 
first studied by Guant e t al (195 \ ) in normal animal s . From 
organ weight data, they concluded that reserpine was a mild 
stimulant of the ad renal cortex, while also possessing the 
ability to depress thymus and gonadal weights of male and fe-
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ma.le albino rats . Accordingly , reserpine acted as a mild 
stressor to which the organism was adapting . 
Christian (1956) studied the chronic effects ( three weeks ) 
of reserpine (6 . 67 mg/ml of drinking water) in mice living i n 
isolation or crowding. Reserpine was found to inhibit the ad-
renal growth associated with each stress and was founj to de-
crease fighting amongst mice subjected to chroni c crowding . 
Some animals after two weeks of i solation were suddenly placed 
in crowded quarters . Reserpine was found to have little effect 
on the environmental stress in mice induced by the preceeding 
change. It was concluded. that reserp i ne was able to inhibit 
the sociological conflicts with no apparent effect on changes 
in environment . 
In contrast Wells et al (1956 ) found reserpine to be a 
potent inhibitor of ACTH release in rats. Reserpine was admin-
istered (2 .5 mg/kg, I. P.) for five days in order to adapt the 
animals to the drug. On the last day the animals were subjected 
to either histamine or e ther stress . The se workers utilizing 
the depletion of adrenal ascorbic acid (AAA) as an index of 
adrenocortical hyperfunction, demonstrated that reserpine was 
an initial stinmlator of stress, but after five days, inhibited 
these super•impos'ed stresses. 
Guillemin (1957), while attempting to determine whether any 
of the proposed neurohumora.l a.gents (Serotonin, Norepinephrine, 
Acetycholine and Histamine) were identical to the Corticotrophic 
Releasing Factor (CRF ) , did not agree with previous findings as 
to the ability of tranquilizers to inhibit acute stressors. In 
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fact, he found that some of these drugs were themse lves potent 
stressors (chlorpromazine and reserpine) although animals in 
this investigation were preinjected with the drugs 7 days prior 
to the initiation of the stress. Guillemin's experiment dif-
fered from previous research in that it utilized a psychologi-
cal stressor, forced restraint stress (holding an animal on 
its back for 90 min.). He observed that while reserpinized 
rats did not resist being restrained, the animal still dis-
played adrenocortical hyperfunction as indicated by the de-
pletion of AAA. 
The ability of reserpine to inhibit environmental stressors 
was again demonstrated by Mahouz and Ezz (1958). Utilizing 
continuous ether anesthesia withe..xmnguination, heat stress, 
and cold stress, they found that reserpine inhibited the usual 
depletion of AAA associated with these stressors. Since re-
serpine was not able to inhibit the usual depletion of AAA by 
various doses of ACTH, and reserpine did inhibit the above 
mentioned stressors, these workers concluded that reserpine 
inhibited the pituitar~-adrenal axis by inhibiting some central 
regulatory mechanism, possibly the hypothalrunµ~. 
A novel theory of reserpine inhibition of ACTH release 
was reported by Kitay et al (1959). They contend that reser-
pine could cause depletion of ACTH, such that a stress follow-
ing its administration would be unable to induce ACTH release, 
because of exhausted ACTH stores. Thus, a drug could appear 
to inhibit the pituitary, but in essence, be actually stimula-
ting it. This research has been extremely controversial, but 
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might help explain previous divergent results concerning drug 
effects on the pituitary-adrenal axis. 
Saffaran and Vogt, (1960), found that 2.5 mg/kg of reser• 
pine (I.P.) caused ACTH release equivalent to that produced 
by the reserpine vehicle . used in this experiment (the identi-
cal vehicle used in this investigation). These workers studied 
the effects of reserpine on the pituitary directly by estima-
ting the ACTH content of the pituitary, by in vitro methods. 
They further demonstrated that the depletion of ACTH by reser-
pine lasted only five days, Thus, they also concluded that at 
best reserpine affected the pituitary-adrenal axis as a non-
specific stressor, 
Recently Montanari and Stockham (1962) 1 have clarified 
to some degree previous conflicting reports. They have demon-
strated that a single 2,5 mg/kg dose of reserpine produces an 
increase in the plasma oortioosterone levels. After the adm1n-
1stra tion of this dose for four days, ether still produced 
adrenocort1oal hyperfUnotion (an increase of the plasma cort1• 
costerone levels ) , This finding, therefore, appears to contra-
dict the predictions of Kitay et al (1959) and Maiokel et al (1961 ) , 
In a series of interesting papers, Maiokel, Westermann and 
Brodie (1962) have demonstrated excellent correlation between 
ACTH release and decreased brain serotonin levels. Maickel 
et al (1961) showed that reserpine was able to stimulate the 
pituitary-adrenal axis as evidenced by increased plasma oort1~ 
oosterone levels. By studying these changes 1t was concluded 
that reserpine (5 mg/kg, I.V.) produced a persistent 
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stimulation of ACTH for at least 20 hours. An equivalent 
effect was also observed during the exposure of rats to 20 
hrs ~ of a cold stressor (4°c.). A similar relationship be-
tween cold stress and reserpine was also demonstrated by their 
ability to deplete the pituitary of its normal stores of ACTH 
by at least 75%. Westermann et al (1962) in their most recent 
publication again demonstrated the ability of reserpine to in-
duce ACTH release, but with selective NE and 5-HT depleters 
(alpha-MMT and various benzoquinolizine derivatives) have pre -
sented excellent evidence indicating the dependence of ACTH 
. release on brain serotonin. With the combined efforts of these 
workers and others {Revizin et al, 1961) they have presented a 
good case indicating the relation between Limbic stimulation 
via reserpine and ACTH release. 
The Present Investigation 
In reviewing the research concerning the mode of action 
of reserpine, the lack of correlation between different investi-
gations at first may not be obvious unless one critically reads 
the papers cited here. The major difficulty in this research 
has been the inability of different investigators to agree on 
approaches and methods in which to study the mode of action of 
reserpine. This is especially true of investigations involving 
· reserpine and its effects on· the pituitary-adrenal axis. 
It has been found very frustrating to observe different 
workers criticizing each other while at the same time they are 
studying reserpine in different systems . A good example of 
this is Montanari's (1962) statement that reserpine does not 
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exhaust the pituitary of its ACTH stores as a means of pitui-
tary inhibition of further stresses as proposed by Maicke]. 
Maickel studied ACTH directly in the pituitary, whereas 
Montanari based his conclusions on adrenal and plasma corti-
costerone levels. He apparently overlooked the possibili ty 
that reserpine may also be acting directly on the adrenal 
cortex. A second example of this criticism is the fact that 
different workers utilize different indexes for determining 
pituitary-adrenal function when criticizing each other as to 
whether reserpine stimulates or inhibits the pituitary adrenal 
axis, (adrenal ascorbic acid and plasma corticosterone). This 
point is of even more importance since Montanari and Stockham 
(1962) have shown that AAA and plasma cortlcosterone do not 
always parellel each other in response to pituitary-adrenal 
stimulation. 
A second criticism of previous research in this area is 
the apparent disregard of basic pharmacological principles in 
studying the mechanism of action of reserpine. Throughout 
pharmacology's short history, much has been learned by study-
ing the effects of chronic doses of drugs, especially in 
relation to the modes of action and side effects of drugs. 
In spite of this, present investigators refuse to study the 
effects of drugs chronically in attempting to fortify their 
own theories as to mechanisms of action. In relation to 
this, few investigators have taken the time out to study 
the chronic effects of reserpine on brain neurohumeral levels 
or the pituitary-adrenal axis. 
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It would seem logical to conclude that if reserpine 
acts by depleting normal brain 5-HT levels after one dose, 
it should also do so after thirty-two or even one hundred 
doses. Reserpine stimulation or inhibition of the pituitary-
adrenal axis should also fall under the same analogy. If 
the thirty-second or one hundredth dose does not induce similar 
effects as the first dose, then either the drug does not act 
via this mechanism or the mechanism is being obscured by a 
se condary cause. Very few workers have utilized such an ap-
proach and because of this dismaying fact, the present inves-
tigation was initiated. 
In view of these statements the following hypothesis 
concerning the relationship between chronic stress and reser-
pine sedation will be presented: 
H;ypothesis I 
If reserpine is either a specific stimulant or depressent 
of pituitary-adrenocortical hyperf'unction in response to stress 
then these effects should be maintained throughout the dura-
tion of the present experiment. 
Hypothesis II 
If reserpine produces its sedative effects by releasing 
either brain NE or 5-HT, then these effects should persist 
throughout the duration of the experiment. 
H;ypothesis III 
If either of the above statements cannot be shown to 
be true, then either reserpine does not act by these mech-
anisms, or a secondary effect is obscuring them. 
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Since the first pages of this dessertation constant re-
ference has been made to animal adaptation to environmental 
changes and the possible effects of drugs on various segments 
of these homeostatic mechanisms (Fig. 1). The above hypotheses 
make 11 ttle mention of too se ideas but were certainly instru-
rrBn t al in their formulation. 
Unfortunately many drugs which affect the C.N.S. are 
usually only studied in normal animals. This may appear irre-
levant to this investigation, but when one considers that drugs 
are usually used in the treatment of diseased states rather 
than normal activity, this fact does have importance. It would 
also be important to know how drugs affect animal responses to 
environmental stressors, since many drugs are used for long 
periods of ti me in human therapeutics. This is especially true 
for reserpine. 
Thus, aside from attempting to learn rrore about the mode 
of action of reserpine, the importance of studying drug effects 
in chronically stressed animals from the view point of human 
pharmacology was a loo emphasized. 
III EXPERIMENTAL 
General 
Male albino rats (150-220 g) of the Sprague Dawley 
strain were used throughout this investigation. Reserpine1 
was dissolved in a solution consisting of: 10% polyethylene 
glycol, 1% benzyl alcohol and 0.25% citric acid. 
The following general procedures were conducted through-
out this investigation except where otherwise stated: 
1. Solutions of reserpine were prepared such that each 
dose was equivalent to 1 ml/kg. 
2. All animals serving as controls received 1 ml/kg, 
T.P., of the reserpine vehicle. 
3. In ea.ch individual experiment a.11 anirr,a.ls were ad-
ministered either reserpine or its vehicle at 8:00 
A .M. 
4. Except where otherwise stated, all animals were 
sacrificed by decapitation 8 hours following the 
administration of reserpine or its vehicle. 
5. All animals used in chronic experiments initially 
weighed between 145 and 160 g. All other animals 
used weighed vetween 190 and 220 g. 
In order to determine the degree of sedation produced by 
reserpine three characteristic symptoms were utilized. These 
were: sedation, bleopharospasm or ptosls (eye closure) and 
1 Kindly supplied by Dr. R. Gaunt, Ciba Pharmaceuticals, Inc., 
Summit, New Jersey 
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diarrhea (Montanari and Stockham, 1962). In normal animals 
this syndrome was always observable indicating the inability 
of animals to develop tolerance to reserpine. Ptosis, how-
ever, was found to be of little quantitative value due to 
daily sutjective interpretations. 
Design of E~periments 
Due to the complex nature of this investigation, it was 
found necessary to perform three m~jor interrelated experiments. 
1. Single and Repeated D)se Recovery Experiments with 
Reserpine 
This experiment was designed to determine the recovery 
of serum corticosterone (KS) and brain serotonin (5-HT) and 
norepinephrine (NE) following one and thirty-two doses of re-
serpine (1 mg/kg, I.P.) respectively. Thirty-two animals 
receiving a single dose of reserpine were sacrificed at either 
4, 8, 12, or 24 hours following its administration. Twenty-
four animals serving as controls were also sacrificed at equi-
valent times. 
Animals were preinjected with the reserpine vehicle (1 ml/kg, 
I.P.) every other day for 14 days to permit adaptation to both 
vehicle and injection procedure. Experiments were conducted on 
the 15th day. 
Similar experiments were conducted following 32 doses of 
reserpine. Twenty-eight animals receiving reserpine (1 mg/kg, 
I.P.) daily were sacrificed at either 8, 24, 80, or 154 hours 
following the last dose of reserpine. An equal number of ani-
mals serving as controls were also sacrificed. In this experi-
ment animals were allowed food ad libitum. 
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2. Effects of Chronic Restraint Stress in Normal and 
Reserp1nized Male Albino Rats 
This experiment was designed to test the previous hypo-
theses made. It was hoped that this experiment would ultima-
tely determine whether reserpine possessed any specific effects 
on the pituitary-adrenal axis. 
One hundred and eighty animals initially weighing 145-160 g 
were used in the experiment. Animals in each experiment were 
divided into four experimental groups. 
1 - CONTROL (These animals received (1 ml/kg, I.P.) the 
reserpine vehicle daily) 
2 - STRESS (Control animals + a daily forced restraint 
stress) 
3 - CONTROL + RESERPINE (These animals received 1 mg/kg, 
I.P. of reserpine daily) 
4 - STRESS + RESERPINE (These animals received 1 mg/kg, 
I.P. of reserpine daily + restraint stress 
daily) 
Individual experiments of 1, 6, 12, 18, and 32 days were 
conducted. Stressed animals were subjected daily to a forced 
restraint stressor for a period of three hours by tying these 
animals on their backs to specially constructed boards (Renaud, 
1959). Stress was initiated 5 hours after reserpine or its 
vehicle was administered to respective experimental groups. 
Animals were sacrificed immediately following release from re-
straint at the termination of the above mentioned experiments. 
The animals of both stress groups were housed singly in 
standard metabolism cages constructed to isolate them from 
light stimuli while not under restraint. Control animals (un-
stressed) were housed in similar metabolism cages, two animals 
per cage; these animals were not isolated fr om light stimuli. 
Urine volume, water and food intake were determined daily 
for all experimental groups in each experiment. Each animal 
was allowed 18 g of purina rat chow daily. This quantity of 
food was based on the average food intake for rats receiving 
chronic reserpine treatment (1 mg/kg, I.P.). 
3. Effects Qf Single ~Repeated Graded Doses £.!.Reser-
pine in Normal ~ ~lbino ~ 
Thia experiment was a second attempt at determining whether 
reserpine possesses any specific effects on the pituitary-adre-
nal axis. It was also utilized to clarify the interrelation-
ships between reserpine sedation and brain 5-HT and NE levels. 
Single graded doses of reserpine, 0.5, 1.0, 2.5, and 5.0 
mg/kg, I.P., were administered to male albino rats (8 animals/ 
dose). Eight hours following administration all animals were 
sacrificed. These animals were also pre1njected with the re-
serpine vehicle as 1n the first experiment (every other day 
for 14 days). 
A repeated graded dose experiment was also conducted using 
64 male rats. These animals were divided into four groups. 
Three groups received different doses of reserpine (0.5, 1.0, 
and 2.0 mg/kg, I.P.); the last group serving as control. All 
animals were sacrificed 8 hours after the 32nd dose of reser-
pine. Dose s of reserpine and its vebicle were administered 
each day at 8:00 A.M. 
In an attempt to separate rats which would be sensitive or 
resistant '00 reserpine, a special feeding and housing schedul0 
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was utilized. This schedule was based on the premise that 
sensitive rats would eat less and thus, present a decreased 
rate of growth. This is a logical statement since the degree 
of reserpine-induced inan i tion is dependent on its dose (Gaunt 
et al, 1954). In relation to sensitive and normal reserpinized 
rats, resistant rats would be expected to eat more and present 
a greater rate of growth. 
The schedule used is as follows: 
1. Animals were allowed 18 g of food/animal for 10 days 
and were housed 20 animals/cage. 
2. Animals were then subdivided by weight groups and 
placed in cages in groups of 10 animals/cage. Food 
was allowed ad libitum. 
3. After 20 days of the experiment animals were again 
subdivided into three weight groups of 6-8 animals 
per group. 
Sacrifice, Removal and Preservation£! Tissue 
Sacrifice was accomplished by decapitation with a manua l 
guillotine1 • Blood was collected in 12 ml centrifuge tubes 
and allowed to stand for 8 to 16 hrs. in a cold room (12°c). 
Blood samples were then centrifuged at 2,000 R.P.M., serum re -
moved by decantation and stored at -10°c until assay . 
Brains were removed within two minutes after sacrifice 
and frozen immediately in test tubes immersed in a free zing 
mixture of solid carbon dioxide and trichlorethylene. The 
brains were later removed from the tubes and preserve d in t1n(Al) 
foil at -10° until assay. 
1 Harvard Instrument Co. 
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Organ Weight Data 
Following the removal of brains, rat carcasses were 
0 placed in a cold room (12 ) and were autopsied no later than 
24 hrs after sacrifice. At autopsy, the adrenals, pituitaries, 
thymus and testes of each animal were removed, freed of fatty 
tissue, blotted and weighed to the nearest 0.1 mg on a micro 
tissue balance. 
After weighing, the adrenal glands were dried to a con-
stant weight in an oven at l05°c. In some instances pituitar-
ies were air dried in a desiccator and weighed (due to the small 
weights involved mean weights were determined by pooling groups 
of pituitaries). 
Chemical Assays 
1. Serum Corticosterone (KS) 
In rats, the major adrenal corticosteroid has been deter-
mined to be corticosterone (Zenker and Bernstein, 1958). KS 
levels were determined according to the speotrofluorometr1c 
method of Guillemin et al (1959) 1n which corticosterone devel-
opes a fluorescent product in 84% H2S04. Fluorescence was read 
on an Aminco-Bowman Spectrofluorometer1 at an activating wave 
length of 470 mu and a fluorescent wave length of 510 mu (photo-
multiplier 'tube = IP21). Standard curves (external standards) 
were prepared by running known amounts of' corticosterone2 (0.2-1.0 
ug/ml) through the assay procedure. Recoveries from serum were 
98±5% (± S.D., N=6). Values were reported as ug/100 ml. of serum9 
~~~~~--~~~~~~~~~~~~~~~~~· 
1 American Instrument Co, In all experiments ut111zing this in-
strument assays were performed in quartz cuvettes ut111zing an 
Xenon light source with a No. 5 slit arrangement. 
2 Kindly supplied by Dr. G. C. Strayer, Sobering Co., Bloomfield, 
N • J • 
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2. Brain Serotonin (5-HT) ~ Norepinephrine (~) 
Brains were homogenized with O.lN HCl in a Teflon Homo-
genizer and a 3-6 ml aliquot of the homogenate (300-400 mg 
of brain/ml) was taken for assay. Assays were usually per-
formed on pooled samples (2-5 brains/pool) except where indi-
cated. Both amines were extracted with an NE butanol extrac-
tion procedure which has also been used to extract 5-HT (Mead 
and ~inger, 1961). Serotonin was assayed by its natural fluo-
rescence at an activating wave length oj 292 mu and a fluore-
scent wave length of 342 mu (photomultiplier tube = IP28) in 
an Aminco-Bowman Spectrofluorometer. Brain NE was assayed by 
the development of fluorescence with potassium ferricyanide 
(Maynert and Klingman, 1962). Its wave lengths for activation 
and fluorescence were respectively 475 mu and 520 mu. It was 
also measured in an Aminco-Bowman Spectrofluorometer (photo-
multiplier tube= IP21). 
Standard curves (external standards) were prepared by 
running known concentrations of both NE1 and 5-HT1 (0.5-5.0 
ug/ml) through the assay procedure. Recoveries from grain 
homogenates were 95±10% (± S.D., N=6) and 76!8% (± S.D., N=l2) 
respectively for NE and 5-HT. Values were reported as uug of 
free base/g of brain tissue. Duplicates for NE determinations 
were run with each assay. Duplication between homogenates for 
each amine was of the order of 97% (S.D.=~3.3%). Maynert and 
Klingman, (1962) reported a s.n. of ±2.7%. 
1 Both amines were obtained from Nutritional Biochemical Corp., 
Cleveland, Ohio. NE was used as the free base, whereas 5-HT 
was used as the Creatinine sulfate. 
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Control ~ 
Before the results obtained from these experiments is 
presented, the validity and variability of the control data 
should be discussed (TABLES I=XV). During the chronic rest1aint 
experiment, controls were separated from experimental animals 
by one closed door. Although no animals were restrained in the 
presence of control animals, they were released from restraint 
in their presence. Aside from the presence of other species in 
the animal room, several other persons conducting research were 
also present at various times . All of these factors, therefore, 
appeared to exert an influence as observed from the presentation 
of control data. Therefore, all anirrals (normal and reserpini-
zed) were subjected to an inconsistent type of stress. If each 
control value is compared against the mean value, this variable 
is demonstratable. Furthermore, the control animals present dur- · 
ing this experiment also exhibited a slight G.A.S. of their cwn. 
The recovery experiments following 1 mg/kg reserpine also 
demonstrate the daily variability of control data (TABLES I & II). 
The results presented and discussed in this investigation 
have all been interpreted in light of this great variability, 
and were compared in some manner with a control value at the 
appropriate day or time of day. 
Although the data presented demonstrate · great variation 
(control and experimental) as demonstrated by the high standard 
deviations, the data presented are considered accurate and valid, 
due to the consistency of the values. 
It should further be added that the organ weight relation-
ships expressed in the following tables and figures, were not 
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expressed as relative weights {'weight/100 g of animal), but 
as absolute weights. This preference was utilized because of 
the large variation in the growth rates of different groups 
of animals (TABLE III). 
Finally, all values reported were analyzed statistically 
utilizing the student "t" test (Burn, 19)2). The level of 
significance used throughout this research was at the 0.05 
level . 
IV. RESULTS AND DISCUSSION 
Single ~Repeated Dose Recovery Experiments 
with Reserpine 
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TABLE t 
'1'BB QOCVIRY OF PITUITARY-ADRENAL P'ONCTION AND BRAIN 
NOREPmEPHRINE A.ND SEROTONIN LEVELS PULW'WING A 
SINGLE mSE OF RESERPINE IN MALE ALBINO RA'l'Sa 
HOUR 
011' 
DAl .. 
12too0 
A.M. 
8:00 
P.M. 1 
8tOO 
A .. M .. 
SERUMb 
OOttTICOSTERONE 
~, (XS) 
"ug/100 ml 
:_ + I 39•0;15.0 (8) 
10,.6-3 .0(8) 
17~. 0;10. 0 ( 8) 
21-'.7-8.0(6) 
BRAIN 
SEROTONIN 
(.5-RT) 
uug/g 
I' 'IJ),lC26 
$86:!'87 
~;g:~i 
3s1;2a 
466-64 
4113!'33 
s29t90 
a - The dose ~t reserpine was l mg/kg, I.P. 
BRADl 
NOREPIREPBRllfB 
(NE) 
uug/g 
" 2862'179 
481%61 
123i'42 
2sot79 
llzi'l.2 
343i'16o 
21s;112· 
623•34 
b - The values 1n this column represent the number ot animals 
1tudied. · .. For brain assays pools ot two bl'a1na eaoh were 
used. · 
s ~~S1gn1t1oai:it tro~ control values. All values are means t 
S.D. · : 
·-:. ,;: .. 
C• ~ A~l an1ma1-• were . a&d.ni•tered. e1tber ditug or Yebhla a~ 
~tOO A.M. · The lower values at each hour (ho!'lz.ontal) are 
oontrol values. 
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Fig. 2. The re la. t1onsh1p be tween pi tu 1 tary·-adrenooortt ca.1 rie -
sponse s and brain neurohumoral changes following a single dose 
of reserp 1ne ( l mg/kg, I.P.) 
Levels of serum oorticosterone ( = ·~,j ), bra.in seroto-
nin ( _A--6) and bra.in noreptnephrine (li---- 1!) were given. Ea.ch 
point represents tbe mean of either 6 to 8 animals or 3 to 4 
brain pools (2 brains/pool) · 
(A) This curve represents the actual serum cort1cos-
terone changes following a single dose of reserpine. 
• 
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TABLE II 
THE RECOVERY OF PITUITARY-ADRENAL PT1NCTION AND BRAIN 
NOREPINEPHRINE AND SEROTONIN LEVELS FOLLOWINGa 
REPE~TED DAILY DOSES OF RESERPINE (32 Days) 
SERUMc BRAIN BRAIN 
CORTICOSTERONE SEROTONIN N OREP INEPHRINE TIMEb 
(KS) ( 5-HT) (NE) 
hr uug/100 ml uug/g uug/g 
27.9~10.5(10) 
25.0-12.0(8) 8 422!"83 605±77 
165d 
498±191 
9.5~4.0(6) 973±546 5 163:t'23s 
15.8-6.0(6) 534!"29 623t29 
24 
16.o:t8.0(8) 620±200 106:t-23S 
27.3'±'9.0(6) 56JI69 645t"l68 
80 
152 47.o:t18.5(4) 
34.ot-17.0(8) 495:!'92 697:!'123 
2~. ?e 
399±92 
a - The dose of reserpine was 1 mg/kg, I.P. 
b - Time refers to time after the last dose of reserpine. 
c - The values in this column represent the number of ani-
mals studied. For brain assays pools of two brains each 
were used. 
d - Two of 3 brains assayed exhibited no NE. 
e - Represents a pooled value (4 brains). 
s - Signi.ficant from control values. All values are means 
± S.D. 
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TIME AFTER RESERPINE (HOURS) 
Fig. 3. Pituitary~adrenocortical and brain neurohumoral re-
covery following thirty-two doses of reserpine (1 mg/kg, I.P.) 
Levels of serum corticosterone ( Ci>---@ ), brain norepin-
ephrine (a--•) and brain serotonh .. ( /\--A ) were given. Time 
refers to the number of hours following the last dose of reser-
pine. ·~ach point represents the mean of 4 to 8 animals or 2 
to 4 pools of brains (2 brains/pool) 
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DISCUSSION 
Reserpine (1 mg/kg, I.P.) was observed to produce acute 
pituitary-adrenocortical activation as indicated by the in-
crease in serum KS levels four hours following its adminis-
tration (TABLE I, Fig. 2). This effect was not observed to 
be continuous with res erpine-induce sedation since at the 
time of maximal sedation, 8-12 hrs following its administra-
tion, serum KS levels were either decree.sing or below normal 
levels. A similar lack of correlation was also observed with 
brain NE and 5-HT depletion. Therefore, pituitary-adrenocor-
tical activation did not appear to be dependent upon brain NE 
or 5-HT levels nor upon reserpine-induced sedation. These re -
sults are in direct conflict with the work of Westermann et 
al (1962 ) who have shown a relationship between reserpine-
depletion of brain 5-HT and increased serum KS levels. Since 
these investigators did not preinject their animals prior to 
drug administration, they may not have observed the desired 
specific effect necessary for such a conclusion. 
Reserpine also appeared to inhibit the diurnal variation 
of serum KS levels at 4:00 P.M. (TABLE I). Whether this ef-
fect was induced by sedation or via pituitary exhaustion is 
not clear. The significance of this finding, however, is evi-
dent after reading the papers of Westermann et al (1962) and 
Montanari and Stockham (1962). These workers have neglected 
to analyze their own data in light of daily serum KS variation, 
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or have made no mention of its presence. Therefore, it is 
difficult to imagine how these workers could conclude that 
reserpine-induced pituitary-adrenocortical activation was 
continuous with its sedative effects. As one can see, reser-
pine appears to possess a stimulating effect when considering 
actual KS levels (TABLE I, Fig. 2A)), whereas when compared to 
control levels, inhibition is evident (at 4:00 P.M.). 
Recpvery from chronic reserpine administration 
I 
1 mg/kg, 
I.P.), however, appears to produce an inhibition of the pitui-
tary-adrenocortical axis variation 24 hrs following its admin-
istration (TABLE II, Fig. 3). The decreased serum KS values 
80 hours following the last dose of reserpine suggests pit1tui-
tary-adrenocortical inhibition by reserpine. This fact is 
further verified by the apparent adrenocortical compensation 
demonstrated by increased serum KS levels 152 hours following 
the 32nd dose of reserpine. Since serum levels were slightly 
&bove normal 8 hrs following reserpine administration on the 
32nd day, subsequent pitu1tary-adrenocortical inhibition may 
have resulted from exhaustion of this system. 
As observed throughout this experiment, the onset of reser-
pine sedation appeared about 4 hrs following its administration 
with maximal sedation appearing 8-12 hrs later. Recovery from 
sedation was evident by 24 hrs. In contrast, throughout the 
latter half of the chronic recovery experiment several animals 
were abnormally excitable 24 hrs following a previous dose of 
reserpine. These animals were extremely excitable and very 
sensitive to handling. They also frequently fought amongst 
themselves. 
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The development of acute sedation correlated well with 
decreased NE levels, whereas brain 5-HT depletion reached a 
maximum four hours following reserpine administration and 
was maintained at this level throughout the 12th hr (TABLE I, 
Fig. 2). Twenty- four hours following a single dose of reser-
pine brain 5-HT appears to be returning to normal in contrast 
to brain NE. Since sedation was also minimal at this time, 
brain 5-HT appears to be a better candidate as mediator of 
reserpine-induced sedation. Although these results are in 
conflict with the work of Brodie et al (1 960) concerning equi-
valent depletion of both amines by reserpine, they do support 
his theory that reserpine mediates its effects through 5-HT 
depletion rather than NE depletion. 
The recovery of brain 5-HT levels following thirty-two 
doses of reserpine took on a different character. Brain 5-HT 
levels were 80% above normal 24 hrs after the last dose of 
reserpine (TABLE II, Fig. 3). This increased level correspon-
ded well with the behavioral excitability observed. 
Since the appearance of maximal sedation was equally pre-
sent 8 hrs following the administration of reserpine through-
out the chronic experiment, this time was used to compare all 
data. When comparing the effects of reserpine on brain neuro-
humoral levels after one and thirty-two doses of reserpine, 
equivalent progressive depletion of both amines was apparent 
(TABLES I and II). However, in subsequent experiments reser-
pine appeared to induce a greater progressive effect on brain 
NE than on 5-HT. The following table has been prepared to 
summarize this and subsequent experiments in order to clarify 
the preceding statements. 
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TABLE IIA 
A COMPARISON OF THE EFFECTS OF RESERPINE 
ON BRAIN NE AND 5-HT LEVELS OBTAINED 
FROM DIFFERENT EXPERIMENTS 
fa DEPLETIONa 
PROGRESSIVE 
DAY 1 DAY 32 DEPLETION 
DAY l/DAY 32 
5-HT 2t% 31% 16% 
NE 37% 73% 51% 
a ·- The values presentAd a.re the means of 
experiments conducted in subsequent 
experiments; TABLES I, II, XI, XII, and 
XV. % DEPLETION refers to the percent 
of control values at that time. 
Therefore, reserpine does appear to have a greater chronic 
effect on brain NE levels than on brain 5-HT levels when com-
paring the progressive depletion of both amines (TABLE IIA). 
It should be added that confirmation has since been obtained 
in this laboratory which re-emphasizes the results of TABLE IIA. 
These observations coupled with the higb brain 5-HT levels ob-
served with chronic recovery experiments (TABLE II), could be 
explained on the basis of an increased rate of 5- HT synthesis. 
In relation to the hypotheses formulated initially, the 
following observations can be ma.de. 
1 - As indicated by the serum KS levels after one and 
thirty·- two doses, reserpine stimulates the pituitary-
adrenocortical axis acutely, but apparentl~ loses 
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its effect during chronic administratio n. However, 
whether the lack of a chronic effect was due to 
pituitary exhaustion it is not clear. 
2 - The comparative effect of reserpine on brain NE 
levels was greater than on 5-HT levels after single 
and thirty-two doses of reserpine. The differences 
in brain levels could be due to an increased rate of 
5-HT synthesis during reserpine treatment. 
IV. RESULTS AND DISCUSSION 
Effects ££. Reser_Eine in Animals Sub jec t~g to 
Daily Forced Restraint Stress 
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TABLE III 
EFFECTS OF CHRONIC RESTRAINT STRESS ON THE FOOD AND 
WATER BALANCE AND MORTALITY RATE OF NORMAL 
AND RESERPINIZED MALE ALBINO RATS (32 days)a 
n 
CONTROL 8 
STRESS 8 
CONTROL + 8 
RESERPINE 
STRESS T 12 
RESERPINE 
WATER 
INTAKE 
ml 
URINE MEAN 
WEIG,HT EXCRETION G~IN/DAY 
ml g 
J.88 
2.84 
1.99 
0.50 
FOOD 
INTAKE 
g 
18 
18 
12.6 
b M.R. 
% 
0 
0 
6 .. 6 
50.0 
a - All values are means of 32 days/animal/day. Where indica-
ted values are means t S.D. Dose of reserpine was 
1 mg/kg, I.P. 
b - Abbreviations - M.R. =Mortality Rate (%Dead/Alive) 
n =Number of animals studied. 
s - Significant from control group. 
x - Significant from both the control and stress group~. 
z - Significant from all previous groups. 
All animals initially weighed about 160 g. 
DAY 
1 
6 
18 
32 
a -
s -
x -
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TABLE IV 
EFFECTS OF CHRONIC RESTRAINT ON THE THYMUS WEIGHTS 
OF NORMAL AND RESERPINIZED MALE ALBINO RA TS a 
CONTROL STRESS 
mg mg 
399:!"104 {8) 
300:1.-44 s 
(8) 
34t:!'86 6) 24~~12 8 
432::r97 (8) 32t~T7s 
385!'63 ( 8) 32~:!64 8) 
CONTROL + 
RESERPINE 
mg 
329±62 
(8) 
313:!14 9 ( 8) 
366!'81 (10) 
298:!°69 8 ( 8 ) 
STRESS + 
RESERPINE 
mg 
J69X6lx 
( 8) 
231tz7s (8 
167!"64 8 x 
(10) 
118'!648 x (12) 
All values are means + 
- S.D. Values in parenthesis 
represent the number of animals used. Dose of reserpine 
was 1 mg/kg, I.P. 
Significant from control group. 
S1gnif icant from stress group. 
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TABLE V 
EFFECTS OF CHRONIC RESTRAINT STRESS ON THE TESTES WEIGHTS 
OF NORMAL AND RESERPINIZED MAIE ALBINO RA TS a 
DAY CONTROL STRESS 
CONTROL + 
RESERPINE 
STRESS + 
RESERPINE 
mg mg mg mg 
l 1.88:!°0 . 28 i.94!0.92 + 1.79-0.30 1.77:!'0.33 
6 2.42to.67 2014::to.52 2.16:to.92 2.11to.40 
18 2.96!0.50 2.90!'0.64 2.74!0.45 2 .53:to.38 
32 2.80:!:'0.45 3.11!0.54 2.05:!0.67 2.20:!0.87 
a - All values are means ± S .D. (None of the values 
presented here were significant from any o ther 
group). The number of animals studied appe ar in 
TABLE IV. Dose of reserpine was 1 mg/kg, I.P. 
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TABLE VI 
EFFECTS OF CHRONIC RESTRAINT ON THE WET ADRENAL "WEIGHTS 
OF NORMA L AND RESERPINIZED MA LE ALBINO RATSa 
DAY CONTROL STRESS CONTROL + RESERPINE 
STRESS + 
RESERPINE 
mg mg mg mg 
1 27 .3:t4. 6 23 . 2:i-1 . 68 27 . 5:r1 . 9 25.8:!2.6x 
6 3.5 .8±6 . 0 34 . 2:t3.5 33 . _5:!'6 .o 35 .1:1'3. 3 
18 Jl. 0!7. 6 -r-5 s 39 . 7- .o 38 . 7! 5.6 39 .0!4.39 
32 37 . 8:!'4 .5 49. 1!7 .68 42 . 7:!·4 . 7 4s .2rs.5s 
a - All values are means t s .D . The number of animals used 
in this experiment appear in TABLE IV . Dose of reserp i ne 
was l mg/kg, I.P. 
s - Significant from control group. 
x - Significant from stress group 
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Fi~. 4. A comoarison of the effects of chronic restraint stress 
organ weights 0f normAl 11nc1 reserpinized male albino rats. 
The wet weights of adrenals ( CJ-- --- -o ) , thymus ( • -. ) and 
are - given. Each point represents the means of 6 to 12 animals. 
on various 
testes (A --·-A) 
Dose of re-
serpine was l mg/kg, I.P. 
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DAY 
1 
6 
18 
32 
a -
8 -
x -
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TAELE VII 
EFFECTS OF CHRONIC RESTRAINT S'l'RESS ON THE 
DRY ADRENAL WEIGHTS OF NORMAL AND 
RESERPINIZED MALE ALBINO RATSa 
CONTROL 
mg 
+ 6.2-0.2 
7.1±1.6 
8.2:t'1.5 
... 9.1 .. 0.4 
STRESS 
mg 
5 6+ s 0 -0.2 
8._s±o . 4s 
10. 5±1 .58 
+ l0.0-2.5 
CONTROL + 
RESERPINE 
mg 
6.8±0.8 
7.7±1.6 
9.8±1.8 
+ 12.3-2.9 
All values are means + S.D. The number of 
studied in th1s experiment appear in TABLE 
of reserpine was 1 mg/kg, I.P. 
Significant from control group. 
Significant from stress group. 
STRESS + 
RESERPINE 
mg 
.5.8±0.5sx 
8.9±1.3 5 
ll.?±2.78 
12.s±1.18 x 
Jl.nimals 
IV• Dose 
DAY 
1 
6 
18 
32 
a - All 
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TABLE VIII 
EFFECTS OF CHRONIC RESTRAINT ON THE % 
ADRENAL DRY WEIGHTS (ADW) OF NORMAL 
AND RESERPINIZED MALE ALBINO RATSa 
CONTROL STRESS 
% % 
23.o:t4.1 24 .3:r2. 7 
21.7±4.2 24.o:r1.5 
24.st4.1 26.4t1.6 
+ 24.7-2.7 21.7!8.7 
CONTROL + 
RESERPINE 
% 
24.e±1.5 
25.3:t1.3 
25.6:t .6 
27.4!4.2 
STRESS + 
RESERPINE 
% 
+ 22.3-2.4 
26.~2.6 
29.2±2.5 
+ 27.0-4.l 
values are (None of the values pre-means .± S.D. 
sented here were significant from any othe r group). 
The number of animals studied appear in TABLE IV. 
Dose of reserpine was 1 mg/kg , I. P • 
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TABLE IX 
EFFECTS OF CHRONIC RESTRAINT STRESS ON THE PITUITARY WEIGHTS 
OF NORMAL AND RESERPINIZED MALE ALBINO RATSa 
DAY 
1 
6 
18 
32 
a -
CONTROL 
mg 
1.09 
1.67 
1.71 
1.76 
STRESS 
mg 
0.89 
l.0.5 
1.65 
1.89 
CONTROL + 
RESERPINE 
mg 
0.90 
1.30 
1.57 
1 • .56 
The dry pituitaries from each group were 
(6-8 p ituitar ie s) for accurate weighing 
expressed as mg/animal ( mean value ). 
Dose of r•eserp1ne was 1 mg/kg, I.P. 
STRESS + 
RESERPINE 
mg 
1 .10 
1.28 
1.25 
1.54 
pooled 
and are 
STRESS I CONTROL + RESERPINE rs---
+20 -i 
l 
I 
...:! 
-Tl.5 ~ p:: 
+10 ~ 0 z 
~ 
+5 0 , &: , I I 
P:l NORMAL - --- - - - - . --1  ---·- ---- --- -- -0 
' 
/ z 
'1 ~ . 
-5 ' D 
' 
' 
I \ '\ ®-----8 I ' z ' I ,/ -----@ I -10 I , P:l . I 
' ® D i I /, ' I I p:: , 
-151: ' , ' ' / P:l ' \ / p.. <!) ' / I I 
' 
/ 
-20 ~--. :' / I , ' I I , ' , , , I 
' 
/ I , I ·@ '@ / @-----@ , I 
' I I - . - ie I I i 6 18 1 6 18 32 1 6 32 32 
DAY OF EXPERIMENT 
on pituitary-adreno-Fig. 5. A - ~omparison of thA effent of chronic restraint s tress 
cortical f'unct5.on of normal and resAroinized male albino rats. 
. Tne weights of dry pi tu1 tari~s (l~--{j) and % adrenal dry 
were -given; - Each point represents the mean of A to .1? animals. weights ( • A) Dose of reserpine 
was 1 mg/kg, I.P. 
I \j\ 0 
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TABLE X 
EFFECTS OF CHRONIC RESTRAINT STRESS ON THE SERUM 
CORTICOSTERONE LEVELS (KS) OF NORMAL AND 
RESERPINIZED MALE ALBINO RATsa 
DAY CONTROL 
ug/100 ml 
1 24.7±16.0 
6 43.0±24.6 
32 33.5±16.9 
STRESS 
ug/100 ml 
71.0±28.1 8 
CONTROL + 
RESERPINE 
ug/100 ml 
51.5±16.2 8 
42.4±28.8 
STRESS + 
RESERPINE 
ug/100 ml 
77.9:±'29.osx 
8).+ • 7±1_5 . 7 SX 
(8) 
50.3:t30.6 
58.7±27.49 
a - All values are means ! S.D. The number of animals 
studied in this experiment appear in TABLE IV. Dose 
of reserpine was l mg/kg, I.P. 
s - Significant from the control group. 
x - Significant from the stress group. 
DAY 
1 
6 
12 
18 
32 
a -
s -
y -
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TABLE XI 
EFFECTS OF CHRONIC RESTRAINT STRESS ON 
BRAIN SEROTONIN (.5-HT) LEVELS OF NORMAL 
AND RESERPINIZED MALE ALBINO RATSa 
CONTROL STRESS CONTROL + RESERPINE 
ug/100 ml ug/100 ml ug/100 ml 
796±43 (4) 961±210 (4) 48.5:tl25 (4) 
698±43 1426:t82J 567::tlll (3) Cld (4) 
67tlf14 67(1:63 3) 522:tl87 (3) 
7(?:tl48 4) 52.5x160 ( 5) 482±45 (4) 
6(55123 55t ..... 123 5) 482:!:'167 ( 6) 
STRESS + 
RESERPINE 
ug/100 ml 
8.50±137 (4) 
960:t443 (4) 
62l~~4 
60.51:41 (6) 
605:!/J9 (6) 
All values are means ~ S,D. The number of brain pools 
studied is represented in the parenthesis (2 brains/ 
pool). Dose of reserpine was 1 mg/kg, I.P. 
Significant from control group. 
Significant from control + reserpine g1•oupu 
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TABLE XII 
EFFECTS OF CHRONIC RESTRAINT STRESS ON THE BRAIN 
NOREPINEPHRINE (NE) LEVELS OF NORMAL AND 
RESERPINIZED MALE ALBINO RATS8 
--
CONTROL + STRESS + 
DAY CONTROL STRESS RESERPINE RESERPINE 
uug/g uug/g uug/g uug/g 
l 242!68 196!61 182!123 177!82 
6 340!218 137!86 182°!91 199!°.52 
12 
-------
__ .... \m ___ 161±16 231:!"37 
18 590±188 497:!'190 11st128 122:t64 8 
24 507±74 560:t38 48•88 102 .. 305 
32 399!96 318:!'23 128:!'619 112!73 
Al l values are + 'I'ne number or bra in pools a - means _ s.n. 
studied appear in TABLE XI. Dose of reserpine was 
1 mg/kg, r.P. 
8 - Sign1f1oant from control group. 
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Fig. 6. A comparison of the effects of chronic restraint stress on serum corti-
costeron~ 1£vels and brain neurohumoral levels. 
Levels of corticosterone ( @- --(j), brain noreplnephr lne (Iii --ti) and 
brain serotontn ( J!K--A) were given. Actual serum KS changes a.re obtained by 
doubling the values appearin~ above. Each poin~ repfesents the means of either 
6 to 12 ·animals or 3 to 6 brain pools (2 brains/pool). Dose of reserpine was 
1 mg/kg, I.P. 
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DISCUSSION 
The Effects of Chro nic Restraint (RS) on th e Pituitary-Adrenal 
~- -- -- -- -~ 
Axis and Various Organ Weights of Normal Male Albino Rats 
According to Selye 1 s theories regarding chronic stress, 
animals respond differently to individual stresso11 s only in a 
quantitative way; the responses all being qualitatively the 
same. Therefore, one of the first objectives of this experi-
ment was to characterize the effects of chronic restraint 
stress in normal animals in terms of the G.A.S. 
It was found difficult to completely characterize the alarm 
reaction, since experiments were designed at six day intervals 
(the alarm reaction usually occurs within the first three d~ys 
of chrinic stress). The alarm reaction was evident to some 
degree by the significant decrease of the thymus weight of 
stressed animals on day one (TABLE IV). There was also a noted 
decrease in the pituitary weight which was als o observed by 
Turner and Tinerty (1956) (TABLE IX). It is difficult to ana-
lyze glandular activity from only a weight change, but on the 
basis of the severity of restraint stress , the loss of weight 
could be due to ACTH and associated chemical depletion during 
extreme activation. 
The significant decrease in wet and dry adrenal weights 
of normally stressed rats after the first day of the experiment 
(TABLES VJ VII) was extremely interesting and unexpected. In 
contrast to this effect, Selye (1950) has observed an increase 
56 
of adrenal weight during the alarm reaction indicating adrenal 
byperf'unction. This effect could also be interpreted as indi-
cating adrenal exhaustion caused by this stress. This fact, 
however, seems highly unlikely. 
Another unexpected finding was the initial lack of effect 
of RS on the testes weight, which acco~ding to Selye (1950), 
should decrease following an acute stress. The present finding 
was confirmed by Albert (1942) who observed a delay in decrease 
of gonadal weights following chronic formalin stress (0.2 ml, 
I.M.). This was also observed in this experiment (TABLE V). 
The ability of normal male albino rats to adapt to chronic 
restraint stress is evident after studying the effects of this 
stress on the thymus, testes, adrenal and pituitary weights 
(Figs . 4 & 5). Following the initial alarm reaction the con-
vergence of all changes towards original or normal levels is 
an excellent example of animal adaptation to external environ-
mental changes. 
The inverse relationship which exists between the pituitary 
dry weight and %ADW of stressed rats appears to be one of the 
clues which may aid in explaining pituitary-adrenal adaptation 
(TABLES VIII~IX: Fig. 5). This relationship appears to confirm 
the earlier observation that a decrease in pituitary weight 
could be interpreted as indicating a state of hyperfunct ion. 
Thus, as an animal adapt s to a stressor, the pituitary becomes 
less active as indicated by the progressive increase of dry 
pituitary (Fig. 3). The progressive decrease in the %ADW also 
indicates a similar decrease in adrenal function. 
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Although an apparent decrease in pituitary and adrenal 
function prevails during adaptation to stress, the serum corti-
1 
costerone (KS) levels exhibit no relative adaptation and appear 
to be maintained at hi gh levels throughout the experiment {TABLE 
X, Fig . 6). If tbe adrenal weights are an indication of corti-
costeroid synthesis and rel ease, then the concurrent maintenance 
of both serum KS and ADW would indicate an increased adrenal 
efficiency during adaptation to stress (TABLES VIII and X). 
Th~ ~ffects of Chronic Restraint (RS) on the Pituitary- Adrenal 
- - --
~ and Var ious Organ Weights of Reserpinized ~Albino ~ 
The mortality rat e of reserpinize d rats subjected to RS 
was extremely high (50%, TABLE III), and clearly indicates the 
inability of reserpinized animals to adapt to chronic forced 
restraint stress. The reserpinized animals subjected to stress 
appear to die from starvation effects which seemed to stem from 
their inability to adapt to the stress since normal reserpinized 
animals demonstrated a mortality rate one- fifth that of the 
stressed animals. The decreased water and food balance caused 
by reserpine, attests to this nonadaptation. 
The most striking e ffect of r eserpine on the first day 
was its apparent inhibition of the effe c ts of RS on the organ 
we i ghts (thymus, pituitary and ad renal) of normal a n imals 
(TABLES IV, VI-IX, Figs . 4 and 5). It i nhibite d the wei ght 
changes by approxima t e ly 50%. The effe c ts of r ese rpine on the 
testes of stre s se d animals is also interesting sinc e it appeared 
to act independ ently of the stre ss by producing a decrease in 
weight (TABLE V). 
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Although reserpine apparently inhibits stress on the first 
day, thereafter, nonadaptation prevails. As observed in Figs . 
4 and 5, organ weight changes are dive r gent in contrast to un-
treated animals under stre s s. There were s ome signs of adapta-
tion as indicated by the increased pituitary wei ght and decreased 
%ADW on the thirty-second day (Fig. 5). 
The serum corticosterone levels indicate tr.at reserpine 
does not prevent animals from achieving adrenal adaptation since 
these l evels are equivalent to those of untreated stressed ani-
mals (TABLE X, Fig . 6). 
That this may not be the case is indicated by the apparen t 
nonadaptation of the pituitary-adrenocortical axis (TABLES VI-IX ) . 
In all cases, the progressive increase of adrenal wet weights and 
ADW's, would indicate increased adrenal function. The apparent 
decrease in dry pituitary weight (TABLE IX), would also tend to 
confirm continued stimulation. Since no other experimental evi-
dence has been presented, these divergent results cannot be ex-
plained at present. However, the great difference between the 
growth rates of stressed and reserpinized stressed animals, ruay 
offer some future explanation. The fact that starvation may 
inhibit the usual detoxication of corticosterone in the liver 
of rats (Herbst et al, 1960), may also aid in explaining this 
discrepancy. 
Re serpine appeared to produce a significant effect of its 
own on the pituitary- adrenal axis. At times, especially at 
the onset of the experiment, the effects of reserpine on organ 
weights of normal animals were almost mirror images of the effects 
of RS in no rmal ani mals (TABLES IV, V, IX, & X). Another inter-
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eating effect appears on the pituitary gland itself (Fig. 5). 
The initial decrease of pituitary weight which occurred on 
day one could be caused by nonspecific effects, and thus, may 
reflect a release of secretory substances. However, on the 
eighteenth day this effect could also be interpreted as complete 
pituitary exhaustion, as predicted by Kitay et al (1959) and 
Maickel et al (1961). It is interesting to note that reserpine 
produces an equivalent effect on the pituitary on day one as 
does RS in normal animals. On the other hand, reserpine plus 
stress produces an inhibition of the decreased pituitary weight 
as caused by stress alone. It thus appears that these effects 
on the pituitary may indicate different mechanisms which are 
antagonistic. Similar differences were also observed on the 
thymus and adrenal weights. 
In a final analysis, reserpine appears to prevent adapta-
tion to RS as evidenced by its divergent effects on various 
organ weight changes. 
The Effects of Chronic Restraint (RS) Stress ~ the Behavior 
and Brain Serotonin (5~HT ) and Norepinephrine (fil~_) Levels of 
Normal and Reserpinized Animals 
Normal animals subjected to RS demonstrated an extreme 
degree of excitability during the first six days of the experi-
ment. This behavioral effect decreased progressively with the 
duration of the experiment indicating behavioral adaptation. 
On the othe r hand, restrained reserpinized animcls were less 
excitable at the o~s et of the experiment but became progressively 
more excitable and difficult to handle as the experiment pro-
ceeded. During the latter half of the experiment reserpinized 
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animals appeared vicious as indicated by their attacks upon 
the investigator. To be more specific, reserpinized animals 
were quite easily tied down throughout the experiment, but 
became increasingly vicious upon release from restraint. 
Generally, most of the stressed reserpinized animals dis-
played some degree of ptosis while under restraint throughout 
most of the experiment . After the sixth day of the experiment, 
the feeble state of the animals (animals weighed about l~O g) 
prevented an accurate analysis of the degree of ptosis and se-
dation. On about the twelfth day the reserpinized animals also 
ceveloped watery secretions around the eyes which made it even 
more difficult to determine the degree of ptosis. Very infre-
quently normally stressed animals developed similar secretions. 
To summarize, reserpinized animals became progressively 
excitable upon release from restraint, although the stres~ was 
initiated with greater ease than with the control animals. Thus, 
there were no indications that reserpinized animals evidenced 
any sort of behavioral adaptation to chronic RS. 
There also appeared to be neurohumoral adaptation occurring 
concurrently with behavioral adaptation. The problem in anal-
yzing these results is the fact that the 5-HT and NE brain levels 
of normally stressed animals were not significantly different 
from control data (TABLES XI-XII). As seen in Fig. 6, there is 
an increase in brain 5-HT levels and a decrease in brain NE 
levels which correspond very well with the general activity of 
the stressed animals during the first six days of the experiment. 
As was pointed out above, these animals were extremely excited 
during the first six days of the experiment. 
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Although there !s little statistical significance to de-
fend the findings presented, the importance of a possible cor= 
rela tion between behavioral adaptation, and brain 5-HT and NE 
levels must not be denied. 
One of' the rro st important observations made in this experi-
ment was the fact that chronic stress (RS) will inhibit the 
usual S=HT releasing effects produced by chronic reserpine ad-
ministration (TABLE XI, Fig . 7). The effects of RS on brain 
NE were lacking as was previously demonstrated acutely by Brodie 
et al (1960). The signifi cance of these findings will be dis-
cussed later. To determine whethel' chronic str ess inhibited re-
serpine sedation a. s we 11 as bra.in .5=HT was very diff' icu l t. In 
relation to the correla. tion between behavior·al and neurohumoral 
adapts. t :ton in re serpinized a.nirnals subjected to chronic stress, 
the fact that stress had no effect on brain NE levels appears to 
associate this amine with the progressive increased behavioral 
activity associated with this group of animals. 
One point, however, was very obvious. Reserpine did not 
induce a progressive depletion of brain 5~HT but it did to brain 
NE (Fig. 4). On the other hand, Brodie and Shore (1957) have 
postulated that reserpine should produce a prog1•ess i ·ve depletion 
of both brain amines since they do so acutelyo The above obser~ 
vations were also present in the first experiment (TABLES I and 
II)o 
.§£,m,ma.r'Y 
In view of the hypotheses pre sented earlier-, this experi~ 
ment has certainly produced effects which were not expected. 
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Therefore, the initial hypothesis will now be discussed in re-
lation to this experiment. 
Hypothesis I - Reserpine has not been found to inhibit 
chronic restraint stress to any degree. In fact reserpine 
appears to be an acute stinru.lator of the pituitary- adrenocorti-
cal axis and appears to prevent animals from adapting to this 
stress. How reserpine prevents adaptation cannot be determined 
at present. 
Hypothesis II - Reserpine do es appear to ceplete brain 5-HT 
equally throughout this experiment. The fact that brain NE was 
depleted progressively throughout this experiment in contrast 
to brain 5 - HT, make s it impossible to conclude as to which neuro-
hormone is responsible f'or reserpine-induced-sedation. The fact 
that it was not possible to positively state whether chronic 
stress inhibits reserpine sedation as it inhibited 5-HT release , 
gives added support to the preceeding statement. 
Hypothesis III - Since there are no clear cut results which 
would e ither prove or disprove the stated hypotheses, there does 
appear to be secondary mechanisms which may be responsible for 
the observed effects. 
The data obtained by chronically stressing reserpinized 
rats has made it necessary to fornru.late two ancillary hypotheses. 
Hypothesis IA - If reserpine is specifically stimulating 
the pi tu 1 tary- adrenal axis, then s ingle and cbr-oni c graded doses 
of reserp ine s hould produce graded effouts on this system . 
Hypothesis TIA - Since reserpine did not induce a progressive 
depletion of 5- HT, but only of NE, and maintained an equivalent 
63 
degree of sedation throughout the experiment, it is postulated 
that r eserp ine is inducing a rap id synthesis o i' 5-HT. 
To t es t these hypotheses, a chr onic grad ed dose exper iment 
i nvolv ing reserpine was also conducted . The above hypotheses 
will be discussed i n vi ew of these three major exper iments. 
IV. RESULTS AND DISCUSSION 
Effects .2.f §ingle !!!£ ReE,eated Graded Doses 
~serp1. n~. 1£ Normal Ma.le 
Albino ~ 
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TABLE XIII 
EFFECTS OF SINGLE GRADED DOSES OF RESERPINE ON 
PITUITARY-ADRENAL FUNCTION IN NORMAL ALBINO RATS 
DOSE 
mg/kg 
oY 
(6) 
0.5 
(8) 
1.0 (8) 
2.5 (?) 
5.0 (8) 
ADRENALz 
DRY 
WEIGHT 
(ADW) 
mg/lOOg 
4.0!0.3 
SERUM 
CORTICOSTERONE 
(KS) 
ug/100 ml 
16.0±4.0 
2i.6:t14.o 
lJ.8!11.6 
27.0:!:'12.oa 
34.0!7.9a 
38.3~12.oa 
WET 
PITUITARY 
WEIGHT 
mg 
-------
4.6:!:0.7 
4.2!0.9 
3.8!0.6 
4.4:to.8 
5.3!0.5 
~i- - Numbers in parenthesis represent the number of animals 
studied. 
+ ~Hf. - All values are means - S.D. 
a - Significant from the control group (0). 
y - These animals were administered 2 ml/kg of a 25% solution 
of the reserpine vehicle. 
z - The organ weights presented are mg/100 g of animal weight. 
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Fig. 7. Effects of single graded doses on pituita.r>y-adrenocortical 
function in normal male albino rats. 
Serum corticosterone ( --~\),pituitary weights ( .A---A), 
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TABLE XIV 
EFFECTS OF REPEATED GRADED DJSES OF RESERPINE (32 days) 
ON PITUITARY-ADRENAL FUNCTION IN NORMAL MALE 
ALBINO RATS 
rosE 
mg/kg 
oY 
( 6) 
o.5 ( 16) 
1.0 
(10) 
2.oIII 
(18) 
2.0 
(6) 
ADRENAL 
DRY 
WEIGHT 
(ADW) 
mg 
9.97!2.6 
l0.0.5±2.8 
10.0 
SERUM 
CORTICOSTERONE 
(KS) 
ug/100 ml 
25.0!12.o 
27.3:!0.o 
25.8:t10.6 
27.9±'105 
27.4±13.6 
18 
+ ~H~ - All values are means - S .D. 
DRY 
PITUITARY 
WEIGHT 
mg 
9.8!o.8 
7.1:!2.4 
8.3!1.1 
8.6'!2.2 
7.9:t1.4 
-------
z - Values in parenthesis represent the number of animals 
studied. 
y - All animals in this experiment were given food ad libitum 
except for this group; they received 18 g/animal. The 
final weights of animals in this exp er iment were as 
follows: ( 0 ) 339 g, (OY) 271, ( 0 .5) 240 g, (1) 220 g, 
and (2.0) 204 g. 
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TABLE XV 
EFFECTS OF SINGLE AND REPEATED GRADED DOSES OF RESERPINE 
ON BRAIN SEROTONIN AND NOREPINEPHRINE LEVELS 
OF NORMAL MALE ALBINO RA TS 
SING LE DO SES REPEATED I OSES (32 Days) 
DOSE 5-HT NE DOSE 5-HT NE 
mg/kg uug/g uug/g mg/kg uug/g uug/g 
0 605~77 498~191 
(7 ) 
.0 577:51.iH!- 245~77 ( 4 )-!!-
o.5 426'!27 76:t5aa ( 5) ( 2) 0.5 516:!:99 
129±84. 
f 4) 
1.0 427t87 72:t51 (10) 563±69 645±168 
1.0 458:!'28 123!]9 
(4) 
(3) 
2.0 461%65 94±57 (4) (2) 
2.5 4102')6 1912'36 
(4) 
2.oIII 6~3;!'79 107!51 (3) 7 9iHH!-5.o 365!56 148!39 {4) 
* - Values in parenthesis represent the number of pooled assays (2-4 brains/pool). 
-iHi- - All values are means ± S.D. 
i!-*i!- - These values a.re significantly different from the values 
above at 2 mg/kg. The values below represent a pool of 
three assays. 
III - Extremely excitable group. 
a - The values in parenthesis in this column represent the 
number of assays in which NE could not be determined. 
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Fig. 8, ? Effects of single and chronic grade d doses of reser-
pine on brain serotonin (5-HT) levels of normal male albino 
rats. 
Single doses ( ..._. ) and chronic doses ( A- --A) are 
given. Each point repr~sents the mean of 3-7 brain pools (2-4 brains/pool). The chronic experiment was conducted for 
32 days. 
DISCUSSION 
~1ng~e graaed aoses of reserp1ne resulted in a dose-re-
sponse effect on the p1tu1tary~adrenal axis (TABLE XIII, Fig. 
7). The sigmoid character of serum KS levels does indicate 
a epeo1f1c stimulatory effect by reserpine. The attempt to 
permit animal adaptation to the vehicle and injection by two 
weeks of preinjeot1on re-emphasizes the specific effects of 
reserpine on this system. However, the vehicle was also ad-
m1n1s tered 1n a greater dose (oa, TABLE XIII). As indicated, 
this concentration also had an effect on the pituitary-adrenal 
axis, but was not as potent a streseor as reserpine. 
The effects of graded doses on adrenal weights are ex-
tremely unusual and do not present the same dosewresponee 
e!'feo t as observed with reserpine and serum KS (TABLE XII'I). 
The character of the pituitary- weights ve, dose of rese~p1ne 
1nd1oates a b1phasio action of reserpine, first st1mula.t1on, 
then 1nh1b1t1on of the p1tuttary-adrenal axis (Fig. 7), The 
complementary nature of the :t'elat1onsh1p between the ADW and 
pituitary weight re-emphasizes this possible b1phae1c effect 
of reserpine on the p1tu1tary ... adrer1al axis. In oontz•ast to 
the b1phas1o e:f'f'eot on th1a system, erum KS 1nd1oatee only 
a monophas1o st1mulat1ng effect by reserpine on the pituitary• 
adrenooort1oal axte, These oonolusione re valid if one con• 
e1de~s an 1norease 1n adrenal weight 1n oontr at to a deor ase 
1n pituitary we1gh.t, ~ an 1nd1oa.t1on of p1tu1tary-e.drenooort1 ... 
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cal axis hyperfunction. The %ADW and dry pituitary weight re-
lationships in normally stressed rats would appear to confirm 
such a conslusion (Fig. 6). 
This effect could be explained if reserpine possessed both 
central and peripheral effects. In support of such a possib111ty, 
Verdesca et al (1961) has shown that 5-HT stimulates adrenal 
function directly, and increases corticosteroid secretion. 
Since reserpine also induces peripheral release of 5-HT (Erspmer, 
1961), a sedative dose could be envisaged as producing both an 
inhibition of the pituitary-adrenal axis centrally, and a stimu-
latory effect peripherally on the adrenal cortex directly. Such 
a mechanism could explain the apparent biphasic effects of sin-
gle graded doses of reserpine. 
The reserpine control animals present during the restraint 
stress experiment, exhibited unusually high adrenal dry weights 
(TABLE VII). This effect was not duplicated in this experiment. 
In several other experiments conducted in this laborato11 y, the 
adrenal dry weights of animals receiving 1 mg/kg of reserpine (32 
days) were 10.0 mg per animal. This apparent discrepancy may be 
due to possible undue stress provided during the restraint stress 
experiment. The high serum KS levels of this experiment, as com-
pared to the first experiment (TABLE X) also indicates that such 
increased stress conditions did exist. 
After thirty-two days of daily administration of reserpine, 
no effective stimulation of the pituitary=adrenal axis was ap-
parent as compared with the effects of single graded doses 
(TABLES XII and XIII). What occurs between the first and thirty-
second day might be explained by three possibilities: 
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1. Reserpine acts as a nonspecific stressor to which 
the animal eventually adapts {TABLE X). 
2. Reserpi ne causes inhibition by contirnled deple tion 
of pituitary stores of ACTH (K itay e t al, 1959 ). 
3. Reserpine produces a direct stinru.latory effect on 
the adrenal gland via peripheral serotonin (5-HT ) 
depletion, to which the adrenal e i tber adapts or 
eventually is its elf exhausted by ch1,onic s t1mula-
t1on. 
Single graded doses of reserpine produced a progressive 
depletion of bra in .5-H1r indicating a causal re la tionsh ip be~ 
tween dos€' and eff'ect (TABLE XV, FigJ 8 ). No such rela tion-
sh 1.p was established for brain NE wb 1ch is in contra.a le ti on 
to Brodie and Shore (1959 ) who have established equivalent 
de pletion of both amines following a s ingle dose of reserpine. 
Since reserpine-induced sedation a.ppear•s to cot relate 
better with brain 5-HT as was observed in previous experiments, 
( TABLE I) it is suggested that reserpine-induced sedation may 
ultimately be caused by bra.in 5-HT release . 
Chronic administration of graded doses of reserpine indi-
cated somewhat of a reversal of 5-HT depletion wrile NE levels 
were lowe r than the first day. In fact, in almost half of 
the assays conducted on animals und er cbronic admin1.stra. tion 
of' reserpine, no NE could be detected ( TABLE XV). 
As indicated in the first experiment (TABLE XI), 1 mg/kg 
of reserpine did not induce progressive depletion of 5-HT 
with time. The 0.5 mg/kg dose of reserpine in this experime nt , 
however, did appear to produce progressive depletion of 5-HT 
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in contrast to the apparent inhibition of 5- HT depletion pro-
duced by 2 mg/kg (TABLE XV, Fig. 8). 
The behavioral sequences involved during this experiment 
clearly indicate the ability of reseriine to produce some exci-
tatory effects. It was observed tbat at about half way tbrcugh 
the experiment, animals at all dose levels became extremely ex-
c 1table 24 hours following a dose of reserpine. - (This was 
al so indicated previously, TABLE I.). There was also evidence 
of extreme excitability in a group of animals receiving 2 mg/kg 
of reserpine. It is interest ing to note that these animals 
evidenced high brain 5-HT levels and a low mean KS level of 18 
ug/100 ml of serum. As indicated in TABLE IV, group III, al-
though extremely excitable, they demonstrated KS levels below 
normal. Thus, stress could not be implicated in producing such 
high 5-HT levels (Fig. 7). 
One of the initial objectives of this experiment was to 
attempt to separate rats resistant or sensitive to reserpine 
in order to obtain added information as to tbe mechanis ms of 
reserpine tranquil1zat1on. However, due to the lack of suff1-
c ient data, these objectives were not satisfied. 
In relation to the ancillary hypotheses presented in the 
previous experiment, there are no c lear indications that chronic 
reserpine treatmen~ produces chronic stimulatory effects on the 
pituitary-adrenocortical axis. 
Tbe previous hypothesis that reserpine is inducing an in-
crease in br~in 5-HT synthesis has also gained further support. 
The reversal of the degree of 5-HT depletion with increasing 
doses of reserpine does lend support to a possible feedback me-
chanism. 
V. GENERAL DISCUSSION 
The basic assumption in this work has been that anim-
als subjected to chronic environmental stressors will respond 
differently to the actions of drugs and thus, alter their 
usual effects. This investigation has demonstrated the util-
ity of studying the effects of drugs in animals under the 
influence of chronic stress, especially those which affect 
the central nervous system. 
At the onset of this investigation, several hypotheses 
were formulated which were then tested by subjecting reser-
p1n1zed rats to chronic restraint stress. As has been noted, 
by necessity, two ancillary hypotheses were formulated and 
tested in order to elucidate the chronic effects of reserpine 
on the brain NE and 5-HT and serum KS. In relation to these 
hypotheses, the following discussions will be utilized in 
relating the results obtained to the mechanism of action of 
reserpine. 
Neurochemical adaptation which appears to parallel be-
havioral adaptation has been characterized in normal and 
reserpinized rats. The increased behavioral activity assoc-
iated with the initiation of restraint stress closely follows 
the increased brain 5-HT levels and decreased brain NE levels, 
both values returning to normal with behavioral adaptation 
(Fig. 6). Serum cortioosterone levels aside from being an 
index of adrenooortical activity, also appear to be an 
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excellent index for behavioral adaptation. 
The results from previous investigations indicate the 
validity of these observations. Thus Garattini et al (1960) 
found that electroshock produced an increase ln brain 5-HT 
levels in rats, whereas Maynert and Clingman (1962) demonstra· 
ted depletion of brain NE in rats following a cold stress (4°c). 
The significance of these findings can be observed 
assuming that depletion of either neurohumoral substance be 
interpreted as a decrease of neurotransmitter release assoc-
iatAd wit!' increased neuronal activity. If' this assumption 
is oorreot, then during the initial phases of chronic stress, 
the activation of an NE dependent excitatory system in con .. 
trast to the inhibition of a 5-HT dependent system, could 
account for the behavioral activity observed. 
Whether these neu rochemic als are actual neurotransmitters 
released from centrally located axons is still controversial. 
Grundfest (1957), in summarizing research from previous years, 
concludes that central nervous transmission is ac~omplished 
via neuroohemioals. The evidence presented in favor of this 
arose from his inability to demonstrate electrically excitable 
central dendrites. Rothballer (1959) and Brodie and Shore (1957) 
also contend that changes in brain NE represent fluotuationt of 
excitatory activity initiated by an adrenergic system. Brodie 
further postulates that 5-HT is released from a cholinergic 
mechanism during depressive activity. 
In relation to these previous investigations, Whittaker 
(1961) and DeRobertis (1962) have isolated both NE and 5 ... HT 
from a centrifuged brain fraction which contained nerve endings. 
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Although these findings are.· not conclusive proof of the 
physiological roles of 5-HT and NE in the CNS, they do give 
encouragement to the interpretations presented in this in-
vestigation. 
So far, these interpretations have been based on release 
mechanisms associated with increased neuronal activity. How-
ever, when one consideres drug effects, different interpreta-
tions can arise. The effects of drugs on neuronal activity 
can be looked at in several ways. First, a drug could stim-
ulate a nerve which would then release a transmitter substancf. 
Secondly, a drug could act by releasing the transm1 tter with-
ou t stimulating the nerve directly. The end result in both 
cases would be the same. The second possibility would assume 
that the transmitter is acting as though its source was stim-
ulated. However, this does not have to be, since many workers 
have shown that reserpine inhibits peripheral nervous trans-
mission by exhausting NE from the ANS (Trendelenburg, 1961). 
Bonnycastle et al (1962) observed an increase in brain 
5-HT levels in rats receiving sedatives such as phenobarbital 
and dilantin. On the other hand, Pletscher et al (1958) obser-
ved a similar increase with Iproniazid, a CNS stimulant. Thus, 
once again these interpretations arrive at neurohumoral cross-
roads. Some light may be shed on this problem through a 
recent paper by Schanberg and Giarman (1962). These wor kers 
found that reserpine increased the ratio of "Fr ee/Bound" 
5-HT in the brain, whereas Iproniazid dec r ease d this ratio. 
They concluded that the increased brain 5-HT levels produced 
by Iproniazid was an increase in the bound fraction, thus 
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decreasing the total amount of 5-HT accessible to postsynaptic 
sites. Here again, if we assume that the free amount of the 
neurohumoral agent 1s associated with inc reased neuronal acti-
vity, 5-HT does appear to be causally related to a depressant 
mechanism. 
Brodie and his co-workers (1961 ) have provided go od evi-
dence that reserpine produces sedation by releasing serontonin 
from its normally inactive sites. They postulate that after 
release, 5-HT then induces CNS depression at some postsynap t1c 
site. They have also demonstrated that cold stress will pre -
vent reserpine sedation concurrently with an inhibition of 
the normal 5-HT depletion. Since NE remains depleted, they 
conclude that reserpine acts via 5-HT and not NE . 
Chronic restraint stress was also found to prevent 5-HT 
depletion by reserpine. However, in these experiments reser-
p1nized stressed animals exhibited increased behavioral excit-
ability concurrently with depleted brain NE, while brain 5-HT 
levels remained approximately normal (Fig. 6). NE is thus 
associated again, with increased CNS excitation. 
It should be pointed out again that stressed animals 
receiving reserpine demonstrate neurotic behavior after re -
lease from restraint, though they appeared to be somewhat 
sedated while under restraint. This observation is extremely 
important for it cannot be concluded that this stress defini-
tely inhibited reserpine-induced sedation. In other words, 
although these animals could have been under sedation, their 
r eactions to change were violent. 
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Reserpine, therefore, appears to be stimulating both an 
inhibitory and excitatory brain mechanism since RS causes only 
NE depletion which is apparently associated with an excitatory 
mechanism. This postulate is correct if the assumptions made 
previously are valid. Trendelenburg (1961) in a recent review 
article concerning the ANS, points out that reserpine produces 
its peripheral effects by complete exhaustion of peripheral 
NE stores. Thus, reserpine produces a chemical sympathectomy. 
Insofar as brain NE is concerned, it could be detected in 
only half of the assays after 32 days of reserpine administra-
tion (total NE depletion was about 90%). Reserpine, there -
fore, may be producing exhausive depletion of the central sites 
of NE as well, thus producing a central hypersensitity s1~1lar 
to nerve postsynaptic hypersensitivity following denervation 
experiments. Such an apparent hypersensitity may be respons-
ible for the behavioral excitation observed in reserpinized 
rats subjected to chronic restraint stress. 
Past investigators have also demonstrated that reserpine 
causes a general release of several amines even including 
histamine in some species of animal (Burns and Shore, 1961). 
Reserpine, therefore appears to be producing a specific effect, 
sedation, through a nonspecific mechanism. Thus, reserpine 
should also induce depletion of brain 5-HT to eventual complete 
exhaustion if its action is a simple matter of preventing var-
ious amines from being bound. Reserpine, however, appears to 
induce an increased rate of 5-HT synthesis through a possible 
feedback mechanism. Such a mechanism was also suspected in 
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relation to MAO inhibitors by Costa et al (1961). 
Reserpine (1 mg/kg) appears to deplete brain 5-HT levels 
equally throughout this investigation (Fig. 6). Since the 
degree of sedation was al so unchanged in no1•mal animals 
throughout the 32 days, it would be logical to assume that 
the rate of 5-HT synthesis and release were equivalent . This 
assumption can be made since the % depletion of 5-HT and seda-
tion are causally related to the dose of reserpine (Fig. 8). 
It was observed that 0.5 mg/kg of reserpine produced a 
progressive depletion of 5-HT over 32 days (Fig. 8). In con-
trast, 2 mg/kg produced an inhibition of 5-HT depletion; some 
animals exhibited levels above normal (TABLE XV). A possible 
5-HT feedback mechanism involving the free to bound ratio of 
this amine may therefore be indicated. Thus, the rate of syn-
thesis of 5-HT increased in some proportion to % depletion. 
As indicated at the 2 mg/kg dose of reserpine, the rate of 5-HT 
synthesis could be greater than its release. 
A second proof of such a mechanism was evident in study-
ing the recovery of brain 5-HT following one and thirty doses 
of reserpine (1 mg/kg), (Fig. 3). The increased brain 5-HT 
levels, 24 hours following the last dose of reserpine, could 
be explained on the basis of an increased rate of synthesis, 
since the 5-HT levels were below normal 8 hours after admin-
,. 
istratior of the dJug. The rate of NE synthesis did not appear 
to change in any experiment conducted. The obvious accumula-
tion of brain 5-HT could be explained on the basis of its in-
ability to cross the blood-brain barrier (Erspamer, 1961). 
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The behavioral sequences observed along with these in-
creased brain 5-HT levels were also interesting. Throughout 
the latter half of this experiment, animals at all doses ap-
peared extremely excitable 24 hours following a previo~s dose 
of reserpine. The animals appeared to be hypersensitive to 
all external stimuli. These behavioral changes could very 
easily be explained if the brain 5-HT is not bound to an intra-
cellular site. If this increased level of 5-HT represents a 
"Free" form, then 1 t could be bloc king its own inhibiting ef-
fects in a manner similar to several cholinerg1c mechanisms 
(Brodie and Shore, 1957). 
The interpretations of these results indicate that reser-
pine may be producing its sedative chronic effects by inducing 
a continuous release of brain 5-HT ("Free"), which is main 
ta1ned by an increased rate of synthesis. 
The fact that progressive brain NE depletion was not paral-
leled by an increased degree of sedation supports the conten-
tion that reserpine is producing its effects via an increase in 
"Free" brain 5-HT levels. 
The ability of reserpine to prevent adaptation was demon-
strated beyond any reasonable doubt. The means by which it 
accomplished this, however, is a very debatable subject. From 
all of the demonstrated effects of reserpine, adaptation to 
chronic RS is prevented by apparent starvation effects, It 
was observed (Tables IV-IX) that none of the organ weight 
changes associated with adaptation in normal animals were 
observable when an animal receiving reserpine was also sub-
jected to RS. The pituitary-adrenal axis, however, appears 
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to be somewhat operable einoe high KS levels are maintained 
even to the 32nd day, {TABLE X), (Fig. 6) .. 
One interesting observation was made by Rosenkrantz and 
Laferte (1960, and Verdesoa et al (1961). These investigators 
have demonstrated that serotonin stimulates the adrenal cortex 
directly, inducing e. release 01' corticosteroids . Since reser• 
pine also depletes peripheral 5·HT in the rat (Erspamer, 1961), 
1 t is ·-very tempting to apeou la. te that the 1 noreased dry we 1gh ts 
of :r:•eserpinized animals (Fig. 4) were due to a dire ct action 
of 5~HT on the adrenal. This fact might also explain the con~ 
flioti.ng results of single graded doses of rese!•pine on adrenal 
dry weights (Fig. 7) and pituitary weights. 
Although all of this information has been accumulated and 
scrutinized, we still cannot answer why a reserpinized animal 
does not adapt to this stressor. Of the three biochem1oal me"" 
che.n1sms assayed, (brain 5•HT and NE; serum KS), the only one 
which appears to be exhausted or below normal 1n reserp1n1zed 
animals subjected to RS, 1s brain NE (Fig. 6). Since one 
would associate non~adaptat1on with the lack of some phys1olo~ 
gioal mechanism, it would be interesting to speculate a relaw 
t1onsh1p 'between the apparent exhaustion of NE with non ... adapta ... 
tion. This reflection becomes even more interesting when one 
compares Cannon's WJrk (1932) with true sympathectomy, with 
Trendelenburg•s remarks (1961) concerning e. drug sympatheotomy 
e.s pro du oe d by reserp1 ne. 
Necina and Krejci (1961), added to this relationship by 
demonstrating that the usual peptic ulcers produced by reser~ 
p1n1zed animals subjected to cold stress (6 hours), could be 
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completely inhibited by administering d1hydroxyphenylalan1ne 
{DOPA), a precursor of NE. They also observed that the usual 
5~ mortality in reserpinized animals subjected to cold stress 
could also be prevented by DOPA. 
In relation to this 1nvest1gat1on, on the 32nd day, brain 
NE was barely detectable. This, of course, 1s no ind1oat1on 
of what occurs peripherally. However, after 32 doses of re-
serpine, the usual spinal reflexes associated with sacrifice 
were completely absent. This very dramatio effect may indi-
cate the loss of all ANS reflex ability. 
In view of this data concerning NE and adaptation to stress, 
it is suggested that NE may play an important role at the t1ssue 
. ' 
level, in enabling animals to adapt to all stresses. 
Initially 1t was mentioned that drugs potentially possess 
the ability to affect several segments of the pituitary adreno~ 
cortical axis (Fig. 1). Chronic restraint stress by its very 
nature stimulates the peripheral side, activating the complete 
chain of command ill1c1t1ng oortioosterone release into the 
' general circulation at the opposite side. Reserpine on the 
other hand, acutely tnduoed oortioosterone release. Where re-
serpine acts, however, is not so clear. 
The ~ depletion of brain 5-HT appears to be somewhat 
causally related to increased serum KS levels. Westermann 
et al (1962) postulated that reserpine induces serum KS re• 
lease by increasing the "Free" brain 5-HT levels in the Limbic 
System of the brain, whioh in turn induces ACTH release, poss1~ 
bly via the CRF of the hypothalamus. If their proposal is 
correct, then reserpine should either induce a similar increase 
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in serum KS levels after 32 doses as after a single dose, or 
should pt•oduce inhibition of the p1tu1tary-adrenooort1cal axis 
by exhaustion. 
In contrast, neither of the above possibilities were clearly 
present in this investigation. Serum KS levels were neither in-
creased nor decreased following chronic administration of reser-
pine. Since chronic bratn S-HT depletion was not causually re-
lated to increased serum KS levels, the hypothesis that ACTH is 
dependent on "Free" brain 5-HT levels, was not supported in this 
1nvest1gat1on. 
That the divergent effects produced by reserpine on p1tu1-
tary-adrenooort 1cal .f'unction (serum KS levels vs. pltuitary-
adrenal weights ) could be due to a possible direct effect of 
peripheral 5~HT on the adrenal cortex, is certainly 1mmagina-
tive. If such an effect were proved, much of the oontrad1ctory 
results obtained with reserpine could be reot1f1ed. 
Thus, where reserpine acts in producing 1ts effects on the 
pitu1tary-adrenooort1cal axis, still remains a mystery. 
Concerning these two hyp®theses, the following final state-
ments are presented~ 
IA. Reserpine does not appear to produce chronic 
p1tu1tary~adrenocort1cal st1mulat1on as indi-
cated by serum KS levels. However, indirect 
data d~es 1nd1oate that reserpine may possess 
a bibasic effect on this system which could be 
eclipsing the true picture. 
IIA. Reserp1ne - 1nduoed brain 5~HT release appears to 
correlate better with sedation than does NE. 
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Proof that reserpine is inducing 5-HT syn-
thesis has been presented. Whether such a 
mechanism can explain the mechanism of 
action of reserpine awaits more persuasive 
evidence correjat1ng reserpine sedation and 
brain 5-HT levels. 
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VI. SUMMARY AND CONCLUSIONS 
The study of the influence of chronic stress in animals 
receiving a drug, especially one which modifies CNS activity, 
was proven to be a very worth while venture. Aside from add-
ing to the information concerning the action of a drug, the 
influence of the drug on chronic stress can also aid in the 
elucidation of basic endocrine mechanisms concerning the stress. 
In view of the experiments conducted in this investigation and 
their interpretations, the conclusions of these efforts are 
now presented. 
1. Animals subjected to a chronic forced restraint stress 
adapted well in terms of Selyers General Adaptive 
Syndrome. P1tuitary-adrenocort1cal adaptation may 
involve an increase in the efficiency of tbis system. 
2. Behavioral adaptation associated with restraint 
stress was observed to be related to brain neuro-
humoral levels. Thus, hyperexcitab111ty was assoc-
iated with increased brain 5-HT levels and decreased 
brain NE levels. 
3. Reserpine (1 mg/kg) prevented animals from adapting 
to the chronic stressor of forced restraint. 
4. It was postulated that reserpine presented adapta-
tion by producing a chemical sympathectomy. These 
results suggest the possible significance of the sym-
pathetic division of the ANS and adrenal catechol 
amines in enabling animals to adapt to chronic stress. 
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5. Reserpinized animals reversed the behavioral adapta-
tion demonstrated by normal animals. The progressive 
increase in behavioral hypersensitivity observed was 
associated with the progressive depletion of bra1n 
NE levels whereas brain 5-HT levels remained normal 
throughout this period of activity. 
6. Evidence was presented that reserpine induced an in-
creased rate of 5-HT synthesis with no similar effect 
on brain NE. The supranormal levels of brain 5-HT 
at higher chronic doses of reserpine and observed in 
brain 5-HT recovery studies, indicates the existence 
of a possible serot1nin feedback mechanism involving 
the bound and free concentrations of this amine. 
These high serotonin levels were also associated with 
behavioral hyperactivity. 
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